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1 Introduction 
1.1  Myeloperoxidase 
 
Myeloperoxidase (MPO, EC 1.11.2.2) is a ~150 kDa, cationic, heme-containing 
enzyme, first described in 1941 by Agner et al. [1, 2] (reviewed in [3]). Expression of 
MPO in humans is restricted to phagocytes, where it is stored particularly in primary 
granules of neutrophils and to a lesser extent in granules of monocytes and tissue 
macrophage subsets (reviewed in [4]). In rodents, MPO is assumed to be exclusively 
expressed in neutrophils [5]. 
MPO catalyzes the generation of highly microbicidal oxidants (reviewed in [6, 7]). 
This process is dependent on the presence of hydrogen peroxide (H2O2). For the 
generation of hydrogen peroxide, superoxide anions (O2
-.) are reduced in an either 
spontaneous or enzymatically-mediated dismutation reaction. Throughout the body, 
there are various sources providing reactive oxygen species (ROS). In phagocytes, 
ROS are predominantly produced by NADPH oxidase 2 (NOX2). In addition to this, 
other members of the NOX family and the mitochondrial respiratory chain may 
provide ROS for the MPO-H2O2 system (reviewed in [8, 9]) [10]. MPO oxidizes 
halides, predominantly chloride, but also bromide and pseudohalides. Thereby, it 
generates extremely reactive hypohalous acids (reviewed in [11]). 
For a long time, the major function of MPO was considered to be the generation of 
reactive oxidants for the inactivation of internalized pathogens. Following 
phagocytosis, MPO is released from primary granules into the phagosome, where it 
mainly generates hypochlorous acid (HOCl) (reviewed in [12]) [13]. Intraphagosomal 
inactivation of pathogens by MPO is predominantly dependent on ROS generated by 
the NOX2 complex, which assembles in the phagosomal membrane upon pathogen 
uptake (reviewed in [14]). However, the function of MPO is more complex than killing 
ingested pathogens by generation of ROS. Beyond that, MPO can be released to the 
extracellular environment (reviewed in [15]) [16, 17]. Secretion can occur either 
directly from primary granules or by formation of neutrophil extracellular traps (NETs) 
[18]. In the extracellular environment, hypochlorous acid can attack any chemical 
group of proteins, nucleic acids, carbohydrates and lipids that can be oxidized and 
thereby disturb the integrity of microorganisms, but also of host tissues (reviewed in 
[4, 19]) [20-25]. MPO-derived oxidants critically impact cellular homeostasis and the 
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initiation and progression of various diseases. MPO was reported to promote various 
sterile inflammatory processes, e.g. cardiovascular and neurodegenerative diseases, 
as well as liver fibrosis in steatosis (reviewed in [3, 7, 26]) [27-30]. In vitro studies 
showed that hypochlorous acid increases cell permeability by chlorination of lipids 
and induces direct cell lysis or apoptotic and necrotic pathways in various cell types 
e.g. epithelial cells, fibroblasts and hepatocytes [31-34]. 
 
 
1.2  Neutrophils 
 
MPO is the most abundant granule protein in neutrophils (reviewed in [7]). In 
human neutrophils its mass was reported to be higher than 5 % of the dry weight of 
cells [35, 36]. MPO levels in murine neutrophils only reach about 10 % of that of 
human neutrophils (reviewed in [7]). Additionally, neutrophils comprise the largest 
number of leukocytes in the human circulation (~ 70-80 %), while in mice only 20-30 
% of white blood cells are neutrophils [35, 36]. 
Beyond MPO, neutrophils carry a variety of antimicrobial molecules within 
intracellular granules e.g. neutrophil elastase, lysozyme and α-defensin [37-39]. 
Together, these molecules are involved in different defense mechanisms of 
neutrophils in various infections, predominantly by bacteria and fungi (reviewed in 
[40, 41]). Neutrophils are professional phagocytes and combat pathogens in the 
circulation and in tissues either by phagocytosis or by release of granule contents to 
the extracellular environment (Fig. 1). Effective inactivation of pathogens is 
dependent on synergistic action of an array of antimicrobial molecules. During 
phagocytosis, release of contents from primary granules to phagosomal 
compartments potently inactivates pathogens (Fig. 1A) (reviewed in [41]). 
By degranulation and NETosis, neutrophils release antimicrobial molecules, including 
MPO to the extracellular environment (Fig. 1B, C) (reviewed in [15, 38, 42, 43]) [44, 
45]. NETs are web-like chromatin structures mainly composed of DNA. These 
structures contain proteins from neutrophil granules and the cytosol (reviewed in 
[46]). Bacteria, fungi and some viruses are trapped and disarmed or killed by 
exposure to antimicrobial molecules [18, 47, 48]. 
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Fig. 1 Major mechanisms of pathogen inactivation by neutrophils [41]. 
Neutrophils can inactivate pathogens by three major mechanisms: (A) Following 
phagocytosis, microorganisms are rendered harmless by ROS or antimicrobial granule 
proteins. Inactivation of extracellular pathogens is achieved by (B) degranulation and (C) 
NETosis via release of granule proteins. 
 
 
1.3  Neutrophils and MPO in anti-viral immunity 
 
As part of the innate immune system, neutrophils belong to the host´s first line 
of defense against invading pathogens. The role of neutrophils in the clearance of 
bacterial and fungal infections is well characterized. However, their contribution to 
antiviral immunity is less clear (reviewed in [49]). 
Indeed, the few studies about the role of neutrophils and MPO during viral infections 
are rather controversial. On the one hand, in mouse models for influenza A virus 
(IAV) infection, neutrophils had a protective role for the host (reviewed in [50]) [51]. 
Furthermore, neutrophil-derived NETs were reported to capture and immobilize 
human immunodeficiency virus (HIV)-1 virions and this mechanism was dependent 
on MPO and α-defensin [48]. On the other hand, massive infiltration of neutrophils in 
infected tissues can result in acute inflammation and damage of non-infected 
bystander cells [52]. In patients with hepatitis B virus (HBV) or hepatitis C virus (HCV) 
infection, MPO plasma levels and infiltration of neutrophils were shown to correlate 
with liver damage [53, 54]. 
A B C 
A B C 
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Thus, depending on the virus, neutrophils and MPO have the potential to ease or 
aggravate the course of an infection. Because of that, it is indispensable that the 
antiviral response of neutrophils is tightly regulated to hold the balance between 
immunoprotection and immunopathology. 
 
 
1.4  Lymphocytic Choriomeningitis Virus (LCMV) 
 
To study the role of neutrophils and MPO during an antiviral immune 
response, we used the model of acute infection of mice with LCMV, strain WE. LCMV 
belongs to the genus of Arenaviruses and was first isolated by Charles Armstrong in 
1933 [55]. 
LCMV is a rodent-borne pathogen with the common house mouse, Mus musculus, as 
primary host. However, exposure to excretions or secretions from persistently 
infected rodents is contagious for humans. Infection of pregnant women can be 
transmitted vertically to the fetus and may result in fetal death or the development of 
severe birth defects [56-58]. In adults, if at all, symptoms of LCMV infection occur 
approximately 8 days after infection and are similar to those of influenza e.g. fever, 
headache, muscle aches and nausea [59]. Invasion of the CNS is very rare and 
mortality in this case is less than 1 % [60]. 
Since its discovery, LCMV has been used to study virological and immunological 
questions [61-63]. By means of LCMV as model pathogen important immunological 
mechanisms i.e. MHC restriction, T cell memory, persistent infections, T cell 
exhaustion and immunopathology have been unraveled (reviewed in [64]) [65-78]. 
LCMV infects cells by attatching to cell surfaces via binding of glycoprotein GP-1 to 
α-Dystroglycan (α-DG) on the cell [79]. The latter has a broad tropism and is 
expressed in various tissues of e.g. the liver, kidney and small intestine [80].  
LCMV is a non-cytopathic virus. Meaning, the infected cell is not visibly affected 
during viral replication or shedding (reviewed in [81]) [82, 83]. Instead, the virus 
induces a vigorous immune response, mediated by cytotoxic T lymphocytes (CTLs), 
which lyse infected cells in a major histocompatibility complex (MHC) class I-
restricted manner. 
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1.4.1  The LCMV-specific immune response 
 
Immunopathology during acute hepatitis is mediated consecutively by NK 
cells, CD8+ T cells and CD4+ T cells (reviewed in [84]) [85]. However, the most 
severe destruction is mediated by CD8+ T cells, since cytotoxic T lymphocytes 
(CTLs) play the key role in virus elimination after acute infection of mice with LCMV 
[86]. Upon acute systemic infection, LCMV epitope-specific CD8+ T cells become fully 
activated cytotoxic T lymphocytes (CTLs), they massively expand (about 16.000-fold) 
and eliminate the virus within approximately 10-14 days [87, 88]. 
CTLs with an LCMV-specific T cell receptor (TCRLCMV) recognize viral peptides 
loaded on major histocompatibility complex (MHC) class I on the surface of infected 
host cells. After antigen encounter, CTLs mediate cytotoxicity by several effector 
pathways (reviewed in [89]). Upon TCR-mediated signaling, the CTL releases its 
effector molecules i.e. perforin and serine proteases, namely granzymes by 
degranulation towards the infected target cell (reviewed in [90]). Perforin-deficient 
mice were reported to have defective ability to clear LCMV infection [91]. When 
perforin is released into the immunological synapse, the intercellular space between 
the CTL and the target cell, it contributes to pore formation in the target cell 
membrane (reviewed in [92]). Granzymes can now enter the pore and induce 
apoptosis of the target cell mainly by induction of the caspase cascade. 
Beyond target cell killing in a perforin-dependent manner apoptosis can be induced 
by receptor-mediated pathways. Engagement of FAS receptor (CD95) on a target cell 
with FAS ligand (CD95L) expressed by a CTL results in apoptotic death of the target 
cell by activation of caspase pathways [93]. These two strategies are responsible for 
most of contact-dependent target cell killing. 
CTLs also secrete pro-inflammatory cytokines, such as tumor-necrosis factor alpha 
(TNFα) and interferon gamma (IFNγ) that can be cytolytic to the target cell. Upon 
infections with intracellular pathogens, IFNγ induces the upregulation of MHC class I 
molecules on the surface of target cells, which increases the chance for cytolysis by 
CTLs (reviewed [94]). Via TNF receptor engagement, TNFα can induce signaling 
pathways that lead to caspase activation and subsequent apoptosis of the infected 
cell (reviewed in [95]) [96]. 
 
                                                                                                                  1 Introduction 
6 
 
During choriomeningitis upon intracerebral infection of the mouse central nervous 
system (CNS) with the Lymphocytic choriomeningitis virus (LCMV), neutrophils were 
reported to be recruited by T cells and to cause vascular leakage and acute lethality 
[97]. Depending on the route of virus inoculation, LCMV can induce further 
immunopathological syndromes. Subcutaneous (s.c.), intraplantar inoculation of 
LCMV into the footpad induces a delayed-type hypersensitivity (DTH) reaction and 
intraperitoneal (i.p.) injection leads to acute hepatitis [98-100]. Little is known about 
the impact of neutrophils on the induction of these immunopathological syndromes 
during infection of mice with LCMV and the contribution of MPO in these models is so 
far unresolved. 
 
 
1.5  Aim of this work 
 
The function of MPO during viral infections is double-edged, since MPO may 
contribute to virus clearance, but also to host tissue damage. So far, the role of MPO 
during LCMV-induced immunopathology remained completely unknown. 
The aim of this study is to elucidate how MPO influences the course of disease 
during acute infection of mice with LCMV. 
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2 Materials and Methods 
 
2.1  Materials 
2.1.1  Mice 
 
Breeding pairs of MPO-deficient (MPO-/-) mice [101] of the C57BL/6 strain 
were kindly provided by Stefan Baldus (Department of Internal Medicine and 
Cardiology, University Clinics Cologne). The mice were heterozygously mated to 
generate wt littermates as controls. 
Mice of the C57BL/6 strain in which the promoter region and first two exons of the 
NOX2 gene (NOX2fl/fl) are flanked by loxP sites [102] were kindly provided by Ralf 
Brandes (Vascular Research Center, University Frankfurt). 
To obtain mice with cell type-specific deletion of NOX2 in myeloid cells NOX2flox/flox 
mice were mated with transgenic mice expressing the Cre recombinase under control 
of the M lysozyme (LysM)-promotor (LysM Crepos [103]), which were donated by Jens 
Brüning (CECAD, MPI for Metabolism Research, University of Cologne, Germany). 
All strains of mice were back-crossed at least 10 times to the C57BL/6J background. 
Genotyping was performed by PCR analysis of tail- or ear-biopsies as published for 
the above listed mouse strains. The mice were bred and maintained under specific 
pathogen-free (SPF) conditions in the Center for Molecular Medicine Cologne 
(CMMC) and were used at an age of 8 to 12 weeks. Experiments were performed in 
accordance with the Animal Protection Law of Germany in compliance with the Ethics 
Committee at the University of Cologne. 
 
 
2.1.2  Virus 
 
The Lymphocytic Choriomeningitis Virus (LCMV), strain WE, was propagated 
and titrated as plaque forming units (PFU) on murine L929 cells, clone L13 as 
described previously [104]. 
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2.1.3  Cell lines 
 
 Simian virus 40 [105] transformed mouse embryonic fibroblasts (MEF) derived 
from C57BL/6 mice (C57/SV) were used as target cells or controls. C57/SV and L929 
cells, clone L13 were propagated in Dulbecco´s minimal essential medium (DMEM) 
supplemented with 5% heat-inactivated fetal calf serum (FCS) at 37 °C and 5% CO2.  
 
 
2.1.4  Cell culture media, chemicals, buffers and solutions 
 
All cell culture media, chemicals, buffers and solutions were of research grade 
and purchased from Biochrom AG, MERCK, ROTH or Sigma-Aldrich, if not specified 
otherwise. All buffers and solutions were prepared using deionised or bidestilled 
water (ddH2O) from an EASYpure® UV/UF water purification unit (Werner 
Reinstwassersysteme), sterilized by autoclaving or sterile-filtered with a 0.2 μm filter, 
if necessary and stored at room temperature (RT) unless specified otherwise. 
 
 
Denotation      Composition/Manufacturer 
 
4-Aminobenzoic acid hydrazide (4-ABAH) 14 mg/mL in DMSO, stored at -20 °C, 
       Cayman Chemicals 
Acrylamide 4K-Solution (40%) Mix  stored at 4 °C, AppliChem 
Amersham ELC Detection reagents  stored at 4 °C, GE Healthcare 
Benzonase stored at 4 °C, Novagen 
Blocking solution (BSA) PBS with 3 % BSA and 0.1 % Triton-
X-100, stored at 4 °C 
Blocking solution (milk) TBS-T with 5 % powdered milk, stored 
at 4 °C 
ß-mercaptoethanol (ß-ME)    0.02 M in ddH2O, stored at 4 °C  
Bovine Serum Albumin (BSA)   stored at 4 °C, Sigma-Aldrich 
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Denotation      Composition/Manufacturer 
 
Buffer for mouse infection     PBS with 1 % FCS and 5 % P/S, 
stored at 4 °C 
Buffer for virus dilutions    PBS with 2 % FCS and 1% P/S, 
for virus titration     stored at 4 °C 
Buffer for organ homogenization   PBS with 1 % FCS and 2 % P/S, 
for virus titration     stored at 4 °     
Buffer for FACS staining    PBS with 0.5 % BSA and 2 mM EDTA,  
       stored at 4 °C 
Buffer for cell sorting    PBS with 2 % FCS and 1mM EDTA,  
       stored at 4 °C 
Collagenase type IV    40 mg/mL in HBSS, stored at -20 °C, 
       Merck 
Crystal violet      ddH20, supplemented with  
       0.2 % crystal violet, 2 % ethanol,  
       11 % formaldehyde    
Cultivation medium     1 x DMEM supplemented with 5 or 
for cell culture and target cells  10 % FCS, stored at 4 °C 
Cultivation medium for T cells    1 x VLE RPMI 1640, supplemented 
        with 10 % FCS, 
1 % P/S and 50 μM ß-ME, stored at 
4 °C  
Dimethylsulfoxid (DMSO)    Merck 
Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH & Co. KG 
FCS       heat-inactivated at 56 °C for 30 min, 
       stored at 4 °C, Biowest 
Formaldehyde, 16 %, methanol-free   Polysciences, Inc. 
Freezing medium     FCS containing 10 % DMSO,  
stored at 4 °C 
Glucose oxidase     Sigma-Aldrich, stored at -20 °C 
Growth medium L929 cells   DMEM, supplemented with 5 % FCS,  
for virus titration    1 % P/S, stored at 4 °C 
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Denotation      Composition/Manufacturer 
 
HBSS, no calcium, no magnesium,  GibcoTM 
no phenol red 
Hoechst 33342     ThermoFisher Scientific 
Laemmli buffer (5x)     60 mM Tris/HCl, 25 % Glycerol 
      10 % β-ME, 2 % SDS 
      0.2 % bromphenol blue in H2O 
      Stored at -20 °C 
Liver digestion medium    DMEM supplemented with 5 %  
     FCS, 1 % P/S, 1 mg/mL collagenase 
     (type IV) 
Lysis buffer for 51Cr-release  1.6 % Triton-X-100 (v/v) in ddH2O, 
stored at 4 °C 
Methyl cellulose medium    20 % 10 x DMEM 
for virus titration    220 mg/L Sodium-Pyruvate  
       7.4 g/L NaHCO3 
       1.16 g/L L-Glutamine  
       2 % P/S 
       10 % FCS 
       54 % ddH2O 
       0.9 % methyl cellulose 
Myeloperoxidase, human    Lee Biosolutions, stored at 4 °C 
Natrium Chloride (NaCl)    AppliChem 
PageRuler Prestained Protein Ladder stored at -20 °C, ThermoScientific 
Paraformaldehyde (PFA) solution  4 % PFA in PBS, stored at -20 °C 
PBS   1 x Dulbecco´s phosphate buffered 
salt solution, pH 7.4, stored at 4 °C  
peqGOLD TriFastTM    stored in the dark at 4 °C, Peqlab 
P/S        penicillin (10000 U/mL) and  
streptomycin (10 ng/mL) in ddH2O, 
stored at -20 °C  
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Denotation      Composition/Manufacturer 
 
Phorbol 12-myristate 13-acetate (PMA)  1 mg in 1 mL ethanol, stored in the  
       dark at -20 °C, Sigma-Aldrich 
Phosphatase inhibitors    stored at 4 °C, Roche 
Powdered milk     Carl Roth GmbH & Co. KG 
ProLong™ Gold Antifade Mountant  ThermoFisher Scientific 
Propidium Iodide     BD PharmingenTM, stored at 4°C 
Protease inhibitors     Roche 
RIPA buffer      150 mM NaCl, 50 mM TrisHCl, 
       1 % SDS, 0.5 % Nonidet P40, 
       0.1 % deoxicolic acid 
RNase A      stored at -20 °C, 
       ThermoFisher Scientific 
RNaseZAP™     Sigma-Aldrich 
Roti-Blot A anode buffer (10x)   Carl Roth GmbH & Co. KG 
Roti-Blot K cathode buffer (10x)   Carl Roth GmbH & Co. KG 
Sodium chromate [51Cr]     400 μL sodium chromate (Na2CrO4), 
       2 mCi/ml, Hartmann Analytics 
Sytox Green 5 mM     stored at -20 °C, 
ThermoFisher Scientific 
TBS       150 mM NaCl, 10 mM TrisHCl 
in ddH2O 
TBS-T      0.1 % Tween 20 in TBS 
TEMED      stored at 4 °C, AppliChem 
TrisHCl buffer     Bio-Rad Laboratories, Inc. 
Triton X-100      Sigma-Aldrich 
Trypanblue solution     1 x ready to use solution  
Trypsin-EDTA solution     10 x trypsin-EDTA solution,  
       diluted to 1 x using sterile ddH2O 
Tween 20      AppliChem 
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2.1.5  Antibodies 
 
Antigen  Specification    Provider 
primary 
 
β-actin  mouse anti-mouse, unconjugated Sigma-Aldrich 
   mAb (clone AC-74) 
   1:10000 for Western Blot 
CD4 (L3T4)  rat anti-mouse APC-, PE- or FITC- eBioscience 
   conjugated mAb (clone GK1.5); 
   1:200 for FACS 
CD8a   rat anti-mouse APC-conjugated   BD Biosciences 
mAb (clone GK1.5);    
   1:200 for FACS 
CD11b  rat anti-mouse APC-conjugated   BD Biosciences 
mAb (clone M1/70);    
   1:200 for FACS 
cl. caspase 3  rabbit anti-mouse, unconjugated  Sigma 
   mAb (clone RM250) 
   1:1000 for Western Blot 
F4/80   rat anti-mouse, PE-conjugated   eBioscience 
mAb (clone BM8);    
   1:200 for FACS 
IFNγ   rat anti-mouse, FITC-conjugated  BD Biosciences 
mAb (clone XMG1.2)    
   1:100 for FACS 
Ly6C   rat anti-mouse, APC-conjugated   BD Biosciences 
mAb (clone AL-21);    
   1:200 for FACS 
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Antigen  Specification    Provider 
primary 
 
Ly6G   rat anti-mouse, unconjugated   BioXCell 
mAb (clone 1A8);    
   400 µg for in vivo neutrophil depletion 
   rat anti-mouse, PE-conjugated   BioLegend 
mAb (clone 1A8);    
   1:200 for FACS 
MPO   mouse anti-mouse, FITC-conjugated  Hycult Biotech 
mAb (clone 8F4);    
   1:50 for FACS 
   1:50 for immunofluorescence 
 
 
Major Histocompatibility Complex (MHC) dextramers 
 
H-2 Db-  H-2Db-restricted immunodominant Immudex 
dextramers  epitope loaded with    (Denmark) 
   GP33-41 of LCMV (KAVYNFATC), 
   GP276-286 of LCMV (FQPQNGQFI) 
   and NP396-404 of LCMV (SGVENPGGYCL); 
   PE-conjugated MHC dextramer; 
   1:100 for FACS 
 
 
Antigen  Specification    Provider 
Secondary 
 
IgG   goat anti-mouse, HRP-conjugated Sigma-Aldrich 
   polyclonal Ab 
1:6000 for Western Blot 
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IgG    goat anti-rabbit, HRP-conjugated  Sigma-Aldrich 
polyclonal Ab 
1:5000 for Western Blot 
IgG   goat anti-mouse, Alexa Fluor 488-conjugated 
polyclonal Ab 
1:500 for immunofluorescence 
 
 
Antigen  Specification    Provider 
isotype control 
 
IgG1   mouse anti-mouse, FITC-conjugated  Hycult Biotech 
mAb (clone MOPC-21);    
   1:50 for FACS 
IgG1κ   rat anti-mouse, FITC-conjugated  BD Biosciences 
   mAb (clone R3-34) 
   1:100 for FACS 
 
 
2.1.6  Kits 
 
Denotation       Composition/Manufacturer 
 
BCA Protein Assay      ThermoFisher Scientific 
Click-iT™ Plus TUNEL Assay    ThermoFisher Scientific 
Cytofix/Cytoperm™ Fixation/Permeabilization  BD 
DNase I       Sigma-Aldrich 
DyNAmo Flash SYBR Green qPCR   ThermoFisher Scientific 
EasySep™ Mouse CD8a Positive Selection  STEMCELL Technologies 
EasySep™ Mouse Neutrophil Enrichment  STEMCELL Technologies 
ELISA mouse MPO      Hycult Biotech 
RevertAid First Strand cDNA Synthesis   ThermoFisher Scientific 
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2.1.7  Technical equipment 
 
Device   Specification  Company 
 
Centrifuge    5417 R    Eppendorf 
Cell counting chamber Neubauer Improved LO Laboroptik 
EasySep™ Magnet  EasyEights™  STEMCELLTechnologies 
Electrophoresis cell  Criterion Cell   Bio-Rad Laboratories, Inc. 
Flow cytometer  FACSCalibur   Becton Dickinson 
Fluorescence microscope IX81    Olympus 
γ-counter    COBRA II    Canberra Packard 
GentleMACS   Octo Dissociator  Miltenyi Biotech 
Imaging system  MF-ChemiBIS 3.2  DNR Bio Imaging Systems 
Incubator    Heracell    Heraeus 
LightCycler® 480  Instrument II   Roche 
Magnetic mixer  RET    IKA 
Megafuge    1.0 R      Heraeus 
Microtiterplate-reader Tecan infinite M1000 Tecan Group Ltd. 
Microscope    DMi1     Leica 
Multimode reader   TrisStar LB941   Berthold  
NanoDropTM   One/OneW   ThermoFisher Scientific 
Protein blotting system Trans-Blot Turbo  Bio-Rad Laboratories, Inc. 
Reflotron   Reflotron® Plus System Roche 
Spring caliper   Oditest   H. C. Kroplin GmbH 
Thermomixer   Comfort    Eppendorf 
TissueLyser   LT    Qiagen 
Vortex   Genie 2   Scientific Industries 
Working Bench   Herasafe    Heraeus 
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2.1.8  Consumables 
 
Denotation       Composition/Manufacturer 
 
Bottle-Top-Filter, 0.45 µm     Nalgene 
Cell Culture Plastic       TPP 
Cell strainer 40 or 70 µm     Falcon 
Cover glass (13 mm)     VWR International 
FACS tubes       BD Biosciences 
Falcon tubes (15 and 50 mL)    Greiner Bio-One 
gentleMACS M tubes     Miltenyi Biotec 
Microscope slides      Engelbrecht 
Reflotron® GOT      Roche 
Reflotron® GPT      Roche 
Syringes and needles      Braun 
Whatman 3 mm (filter paper)    GE Healthcare 
Whatman Nitrocellulose membrane   GE Healthcare 
 
 
2.1.9  Software 
 
Denotation       Composition/Manufacturer 
 
Cell Quest Pro      Becton Dickinson 
Fluoview FV1000 Ver. 1.7a    Olympus Corporation 
GraphPad Prism 7      GraphPad Software, Inc. 
ImageJ 1.46h software     Wayne Rasband 
Office Professional Plus 2010    Microsoft 
Photo Shop CS3      Adobe 
Sigma Plot 13.0      Systat Software, Inc. 
 
 
                                                                                                2 Materials and Methods 
17 
 
 
2.2  Methods 
2.2.1  Cell culture 
 
 Cells were cultured under sterile conditions at 37 °C in a humid atmosphere 
containing 5 % CO2. Cells were grown and maintained in tissue culture flasks and 
passaged in a ratio of one to five every 2-3 days after treatment with trypsin-EDTA. 
For long-term storage at -150 °C, cells were suspended in FCS containing 10 % 
DMSO. 
 
 
2.2.2   Induction of immunopathological syndromes 
2.2.2.1 Infection of mice with LCMV 
 
For infection of adult mice (6 to 8 weeks of age) with LCMV, strain WE, 
plaque-forming units (PFU) were converted into infectious units (IU) by multiplying 
the PFU with a factor of 10 as previously described [106]. To induce LCMV-mediated 
hepatitis, mice were infected by intraperitoneal (i.p.) inoculation of 1 x 106 IU of 
LCMV in PBS with 1 % FCS and 5 %. For delayed-type hypersensitivity (DTH) 
reaction LCMV was subcutaneously (s.c.) inoculated at a dose of 1 x 105 IU into the 
right hind footpad. To induce choriomeningitis mice were infected by intracranial (i.c.) 
injection of 103 IU of LCMV. 
 
 
2.2.2.2 LCMV-induced choriomeningitis 
 
Following i.c. injection of 103 IU of LCMV, mice were monitored for their clinical 
symptoms. Initially, mice were inspected and weighed daily. After first appearance of 
symptoms, mice were observed at 6 h intervals. 
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2.2.2.3 Delayed-type hypersensitivity (DTH) reaction 
 
To induce DTH reaction, 105 IU of LCMV were subcutaneously (s.c.) 
inoculated into the right hind foot pad. From day 5 onwards, footpad swelling was 
measured daily with a spring caliper (Oditest, especially equipped with a soft spring, 
H. C. Kroplin GmbH, Schluchtern. Germany). The swelling was expressed as the 
factor of the thickness of the inoculated foot to the thickness of the contralateral non-
inoculated foot [107, 108]. 
 
 
2.2.2.4 LCMV-induced hepatitis 
 
Mice were infected i.p. with 106 IU of LCMV. At the indicated days, serum 
samples were prepared to measure activity of the hepatic enzymes alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) with the appropriate 
test strips using the Reflotron Plus System according to the instructions of the 
manufacturer (Roche).  
Additionally, liver sections were prepared for histopathological analysis in cooperation 
with Dr. Katharina Pütz, Institute for Pathology, University Hospital Cologne and Dr. 
Sonja Djudjaj, Institute of Pathology, University hospital RWTH Aachen. After 24 h of 
fixation in 4 % buffered formalin, liver specimens were embedded into paraffin. 
Histological quantitative examination of liver fibrosis was performed after hematoxylin 
and eosin (H&E) staining. Inflammatory activity (i.e. periportal or periseptal interface 
hepatitis, confluent necrosis, focal (spotty) lytic necrosis, apoptosis and focal 
inflammation as well as portal inflammation) was assessed according to the Ishak 
score [109]. 
 
 
2.2.3  Virus titration 
 
The WE strain of LCMV was propagated and titrated as plaque-forming units 
(PFU) on L929 cells as previously described [110]. Viral loads in spleen or liver 
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samples were titrated as PFU per gram. At the indicated days post infection (p.i.), 
organs of LCMV-infected mice were collected. The weight of organ pieces was 
determined and organ samples were homogenized in homogenization buffer 
supplemented with 1 % FCS and 2 % P/S by use of M-tubes in the gentleMACS Octo 
Dissociator (program protein_01). The samples were centrifuged for 10 min, at 4 °C 
and 300 x g, aliquoted and stored at -80 °C. 18 h prior to virus titration, 2 mL of L929 
cell suspension at a density of 1.215 x 105 cells/mL were seeded into 6-well plates 
and incubated at 37 °C and 5 % CO2. On the following day, the homogenized spleen 
and liver samples were thawed and diluted in 10-fold steps in PBS supplemented 
with 2 % FCS and 1 % P/S. For homogenized organ samples from days 6, 8 and 10 
p.i., a serial dilution of 10-1, 10-2 and 10-3, for days 2 and 4 p.i. 10-3, 10-4 and 10-5 for 
the spleen and for the liver 10-1, 10-2 and 10-3 was used. Medium from the 6-well 
plates was aspirated carefully and 100 μL of the dilution of each sample was applied 
per well. Each dilution was analyzed in duplicates. After 30 min incubation at 37 °C 
and 5 % CO2, cells were covered with 2 mL methyl cellulose medium. After 3 days of 
incubation at 37 °C and 5 % CO2, 1.5 mL growth medium for virus titration was added 
per well. On the next day, medium was removed and 1 mL crystal violet was added 
per well and cells were fixed and stained. After 15 min of incubation, plates were 
rinsed with VE-water and dried for analysis. 
 
 
2.2.4   Preparation of single cell suspensions 
2.2.4.1 Single cell suspension from the spleen 
 
At the experimental day, animals were sacrificed and their spleens were 
removed under sterile conditions. Single cell suspensions were obtained by gently 
squeezing the spleen and passing cell suspensions through a 70 μm nylon mesh with 
the plunger of a 3 mL syringe. Cells were centrifuged at 300 x g, for 10 min at 4 °C 
and cell pellets were resuspended in 5 mL T cell cultivation medium or buffer for 
FACS staining and passed through a 70 µm nylon mesh again. Viable cells were 
counted by Trypanblue exclusion in a Neubauer chamber. 
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2.2.4.2 Single cell suspension from the liver 
 
At the experimental day, animals were sacrificed and their livers were perfused 
with 10 mL ice cold 0.9 % NaCl in a syringe by puncturing the portal vein and cutting 
the inferior vena cava to allow the fluid to flow freely through the liver until the liver 
turned brighter. The liver was removed and cut into small pieces. Liver digestion was 
performed with 5 mL pre-warmed liver digestion medium on a magnetic stirrer at 37 
°C for 30 min. After digestion, the cell suspension was taken up in 20 mL ice cold 
PBS to stop the enzymatic activity and passed through a 70 µm nylon mesh. Cells 
were centrifuged at 50 x g, for 10 min at 4 °C. After centrifugation, hepatocytes made 
up the cell pellet and leukocytes were in the supernatant. For continued use of 
leukocytes, cells were centrifuged twice at 300 x g, for 10 min at 4 °C to get rid of 
remaining collagenase. For continued use of hepatocytes, cells were centrifuged 
twice at 50 x g, for 10 min at 4°C. Afterwards both cell types were resuspended in 5 
mL cultivation medium or buffer for FACS staining. Viable cells were counted by 
Trypanblue exclusion in a Neubauer chamber. 
 
 
2.2.5  Immunomagnetic enrichment of CD8+ T cells from the spleen or the liver 
 
For positive selection, CD8+ T cells were immunomagnetically enriched from 
splenic or hepatic cell suspensions (2.2.4.1 and 2.2.4.2), using a combination of 
CD8α-specific Abs following the manufacturer’s instructions (STEMCELL 
Technologies). After 3 min of incubation at room temperature (RT), cells were 
magnetically labelled with dextran beads for 3 min at RT. Samples were placed in 
either 15 mL Falcons or FACS tubes into the EasySepTM “EasyEightsTM” magnet for 
10 min at RT. Magnetically labelled cells were retained in the tube, while unlabeled 
cells were aspirated. This step was repeated twice. After removal from the magnetic 
field, cells were resuspended in buffer or medium, centrifuged and counted by 
Trypanblue exclusion in a Neubauer chamber. The frequencies of enriched CD8+ T 
cells were assessed by flow cytometry to be between 95–98 %. 
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2.2.6  Immunomagnetic enrichment of neutrophils from the bone marrow 
 
Mice were sacrificed by cervical dislocation and the skin and muscles were 
removed from the hind legs. Afterwards, the legs were detached from the mouse and 
the ends of the femur and shin were opened. The opened bones were rinsed with 5 
mL VLE RPMI 1640 medium, using a syringe with a thin needle (0.6 x 30 mm). The 
released bone marrow was resuspended and collected in a 50 mL falcon tube.  
For negative selection of neutrophils, other cell types in the cell suspension were 
immunomagnetically removed, using a combination of specific Abs following the 
manufacturer’s instructions (STEMCELL Technologies). After incubation for 15 min at 
4 °C, cells were washed and a biotin selection cocktail was added, followed by 
incubation for 15 min at 4 °C. Afterwards, magnetic particles were added and cells 
were incubated for another 10 min at 4 °C. The tubes were placed in the magnetic 
field and labelled cells were kept in the tube, while enriched neutrophils remained 
unbound in the supernatant. The frequencies of enriched neutrophils were assessed 
by flow cytometry to be between 80–90 %. 
 
 
2.2.7  Assay for virus-specific cytotoxicity of CD8+ T cells 
 
 The virus-specific cytotoxic activity of CD8+ T cells from the spleen or the liver 
was measured in 51Chromium ([51Cr])-release assays according to Brunner et al. 
[111] with modifications [112]. 
 
Effector cells 
Total splenocytes, enriched splenic or enriched hepatic CD8+ T cells were used as 
effector cells. CD8+ T cells were immunomagnetically enriched from splenic or 
hepatic single cell suspensions of mice acutely infected with LCMV on days 7 and 8 
p.i., as described under 2.2.4.1 and 2.2.4.2. Effector cells were adjusted to 3 x 106 
cells/mL in RPMI medium supplemented with 10 % FCS, 1 % P/S and 50 μM ß-ME. 
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Target cells 
C57/SV target cells were plated at a density of 5 x 105 or 1 x 106, respectively, into 
10 cm cell culture dishes two days before the experiment. After attachment, target 
cells were infected with LCMV at an MOI of 0.01. As negative control, non-infected 
fibroblasts were used. 1 x 106 target cells were incubated with approximately 50 µCi 
of [51Cr] sodium chromate (Hartmann Analytics) for 60 min at 37 °C, washed three 
times and adjusted to a density of 3 x 104 cells per mL. 
 
Procedure 
In three replicates, 200 μL of the effector cell suspension was dispensed in 96-U 
bottom plate and diluted 1:2 three times, to get effector to target ratios of 100:1, 50:1, 
25:1 and 12.5:1. Afterwards, 100 μL of the target cell suspension was added to each 
well with effector cells. The spontaneous release of [51Cr] by [51Cr]-labelled target 
cells was determined in 6 wells without effector cells to be less than 9 % of the 
maximum release. The maximal [51Cr]-release was determined by target cell lysis in 
100 µL 1.6 % Triton X-100. The virus-specific cytotoxic activity of CD8+ T cells was 
determined after 4 h incubation at 37 °C and 5 % CO2. Cells were spun down and 
100 μL of cell-free supernatants was harvested. Supernatants from each well were 
measured in a γ-counter to detect the amount of [51Cr] released by target cells as 
counts per minute (cpm). The mean of the 4 replicates was calculated before the 
virus-specific lysis of target cells was calculated with correction for spontaneous lysis, 
as following for each effector to target ratio: 
 
% specific lysis = (cpm sample – cpm spontan) / (cpm maximal – cpm spontan) x100 
 
 
2.2.8  Stimulation of LCMV-specific CD8+ T cells 
 
To investigate the role of MPO on IFNγ production by CD8+ T cells, the 
intracellular accumulation of IFNγ was analyzed. To this end, enriched CD8+ T cells 
were co-incubated with LCMV-infected fibroblasts (MHC class I restriction to CD8).  
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2.2.8.1 Preparation of target cells for CD8+ T cell stimulation 
 
 For antigen-specific stimulation of enriched CD8+ T cells, LCMV-infected 
C57/SV target cells were prepared as described under 2.2.7. 
 
 
2.2.8.2 Antigen-specific stimulation of CD8+ T cells 
 
For measurement of intracellular accumulation of IFNγ, 1 x 105 enriched 
splenic or hepatic CD8+ T cells were incubated for 4 h with either LCMV-infected or 
non-infected C57/SV fibroblasts. To prevent secretion of IFNγ, cells were treated with 
1 µL BD GolgiStopTM (BD Biosciences) 1h prior to stimulation until fixation. 
 
 
2.2.9   Flow cytometry 
2.2.9.1 Staining of surface molecules 
 
The frequencies of cells or expression intensities of surface molecules 
(indicated as mean fluorescence intensity (MFI)) were determined by flow cytometry. 
Cells were washed with PBS supplemented with 0.5 % BSA and 2 mM EDTA. To 
avoid unspecific Ab binding and staining of cells, 1x106 cells were incubated with 1 
µL FcR Block™ for 10 min at 4 °C. Staining was performed for 15 min with 0.5 μg of 
fluorochrome-conjugated mAb specific for CD4, CD8α, CD11b, F4/80, Ly6-C or Ly6-
G at 4 °C in the dark. After incubation, cells were washed twice with cold PBS 
supplemented with 0.5 % BSA and 2 mM EDTA and analyzed by flow cytometry 
using a FACSCalibur (BD). 
LCMV-specific CD8+ T cells were detected among spleen or liver cells of C57BL/6 
mice by using PE-conjugated H-2Db-dextramers loaded with either of the three H-
2Db-restricted immunodominant epitopes of LCMV (GP33-41, GP276-286, and NP396-404) 
(Immudex, Copenhagen, Denmark). Dot plots of total splenocytes or liver leukocytes 
from C57BL/6 mice displayed co-staining for H-2Db-restricted immunodominant 
epitopes GP33-41, GP276-286, and NP396-404 with CD8. 
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The frequencies of LCMV-specific CD8+ T cells were calculated as follows: 
 
% TCRLCMV
+ CD8+ cells / % CD8+ spleen cells x 100 
 
Bar charts show the percentage of CD8+ spleen cells from C57BL/6 mice expressing 
TCR in sum for the three major immunodominant H-2Db-restricted epitopes GP33-41, 
GP276-286, and NP396-404. 
 
 
2.2.9.2 Staining of intracellular molecules 
 
For analysis of intracellular IFNγ and MPO, 1 x 106 splenocytes or liver 
leukocytes were washed twice with PBS and fixed with 100 µL 
Fixation/Permeabilization solution (BD Biosciences) in a 96-U bottom plate for 20 min 
at 4 °C. Afterwards, cells were washed twice with 1 x Perm/WashTM (BD Biosciences) 
with 250 µL/wash total volume to remove all traces of Fixation/Permeabilization 
solution. Primary mAbs were diluted in 50 µL 1 x Perm/WashTM and added to fixed 
cells for 30 min at 4 °C. After two times washing with Perm/WashTM in 250 µL/wash 
total volume, cells were analyzed for intracellular IFNγ and MPO expression by flow 
cytometry. 
 
 
2.2.9.3 MPO cytotoxicity assay with murine primary hepatocytes 
 
Hepatocytes were isolated according to procedure under 2.2.4.2. Hepatocytes 
were seeded at a density of 2 x 105 / mL in DMEM with 1 % P/S without FCS in a 24-
well plate. Cells were incubated with either 0.1 U/mL Glucose oxidase (GOX), 0.1 
U/mL MPO or 1.0 U/mL MPO alone or in combination with GOX and 0.1 U/mL or 1.0 
U/mL MPO. Control cells were left untreated. After incubation for 4 h at 37°C, specific 
cell death was assessed by flow cytometry via Propidium iodide staining. 
Hepatocytes were analyzed according to appearance in the FSC and SSC and 
spontaneous cell death of untreated cells was substracted from data obtained from 
treated cells. 
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2.2.9.4 SYTOX Green NETosis assay 
 
Inactive neutrophils were enriched from the bone marrow of naive mice 
according to the procedure described under 2.2.6. Neutrophils were adjusted to a 
density of 1 x 106 cells/mL and 5 x 105 cells were seeded in a 48-well microtiterplate. 
Cells were stimulated with either 25 nM PMA, or LCMV at MOI 10 and MOI 100 for 4 
h at 37 °C and 5 % CO2. Controls remained untreated. After incubation, cells were 
washed twice with HBSS and adjusted to a density of 1 x 106 cells/mL, 100 µl of cell 
suspension was used for flow cytometry. Extracellular DNA was stained with 100 nM 
of cell impermeable dye SYTOX Green for 15 min at 4 °C, followed by two washing 
steps with HBSS. Extracellular DNA released by neutrophils was analyzed by flow 
cytometry. 
 
 
2.2.9.5 Cell cycle analysis of hepatocytes using propidium iodide 
 
 Cell cycle analysis of hepatocytes was performed by quantification of DNA 
content with propidium iodide by flow cytometry. Primary hepatocytes were isolated 
as described in 2.2.4.2. Cells were fixed in cold 70 % ethanol for 30 min at 4 °C. 
Afterwards, cells were washed twice in PBS and centrifuged at 850 x g for 5 min. The 
cell pellet was taken up in 1 mL PBS. As propidium iodide also stains RNA, cells 
were treated with 1 µg RNase A for 15 min at 37 °C. For FACS analysis 150 µL of the 
cell suspension was taken up in 350 µL FACS buffer and DNA was stained by 
addition of 0.5 µg propidium iodide and analyzed immediately. 
Cells that are in the S phase will have more DNA than in the G1 phase and cells in 
the G2 phase will be approximately twice as bright. 
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2.2.10    Western Blot analysis of cleaved caspase 3 
2.2.10.1 Homogenization of liver tissue 
 
Freshly isolated liver tissue (~10 mg) was taken up into m-tubes (Miltenyi 
Biotec) in 500 µL RIPA buffer with benzonase and protease/phosphatase inhibitors. 
Tissue was homogenized using GentleMACSTM Octo Dissociator (Miltenyi Biotec) at 
program protein_01. Homogenates were centrifuged at 836 x g, for 10 min at 4 °C, 
the pellet was discarded. Lysates were transferred into 1.5 mL Eppendorf tubes 
followed by incubation at 95 °C for 5 min. After short condensation on ice, the 
samples were briefly centrifuged. Protein concentration was determined using BCA 
Protein Assay Kit in accordance with the protocol of the supplier (Pierce, Thermo 
Scientific). Finally, protein concentration was adjusted to 35 μg  in 5 x Laemmli buffer 
and H2O. 
 
 
2.2.10.2 SDS-PAGE and Western Blot 
 
Prior to SDS PAGE, the lysates were incubated at 95° C for 10 min. SDS 
PAGE was performed according to the manufacturer´s protocol (Bio-Rad 
Laboratories, Inc.), using a Criterion Cell filled with (1 x) TGS running buffer and 
Criterion Cassettes containing a 14 % Tris/HCl gel for cleaved caspase 3 blot. After 
SDS-PAGE, proteins were transferred onto a nitrocellulose membrane according to 
the manufacturer´s protocol (Bio-Rad Laboratories, Inc.) using a Trans-Blot Turbo 
system. 
In order to block unspecific binding sites, the membranes were incubated in milk 
blocking solution for 30 min at RT. Afterwards the membranes were incubated with 
primary Ab in blocking solution overnight at 4 °C. Monoclonal Abs against cleaved 
caspase 3 and β-actin (diluted in milk blocking solution) were from Sigma-Aldrich. 
Unbound Abs were removed by triple washing of the membrane with TBST. 
Thereafter, membranes were incubated with HRP-conjugated secondary Abs in 
blocking solution for 60 min at RT. Again, unbound Abs were removed by washing 
two times with TBST and once with TBS. The immune complex was visualized using 
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Amersham ELC Detection reagents (GE Healthcare) and detected using the MF-
ChemiBIS 3.2 imaging system (DNR Bio Imaging Systems). PageRuler Prestained 
Protein Ladder (Thermo Scientific) was used for identification of protein size. Specific 
bands on immunoblots were quantified by densitometry using ImageJ 1.46h software 
(Wayne Rasband, NIH, USA). 
 
 
2.2.11 Quantification of MPO in the plasma and liver tissue homogenates 
 
At the experimental days, blood was collected from the superficial temporal 
vein of mice. Plasma was prepared by use of Mircovette 500 LH according to the 
manufacturer´s protocol (Sarstedt). After incubation for 5 min, blood samples were 
centrifuged for 5 min at 2000 x g and plasma was aliquoted and stored at -80 °C. For 
liver tissue homogenization, snap-frozen tissue was prepared as described under 
2.2.10.1. Protein concentration was determined using BCA Protein Assay Kit in 
accordance with the protocol of the supplier (Pierce, Thermo Scientific). 
Systemic levels of extracellular MPO in the plasma of mice and total protein levels in 
liver tissue homogenates were analyzed with the MPO mouse ELISA kit 
(HycultBiotech) according to the manufacturer´s instructions. 
 
 
2.2.12   Quantitative real-time PCR 
2.2.12.1 RNA isolation and cDNA synthesis 
 
To obtain total RNA from liver tissue, peqGOLD TriFastTM was used according 
to manufacturer’s instructions (peqlab).  
The RNA yield was quantified by NanoDropTM Spectrophotometer (ThermoFisher 
Scientific). The quality of RNA was determined through the ratio of A260/A280 (ratio 
of ~2.0 is accepted). DNA digestion was performed using the DNase I kit according 
to the manufacturer´s instructions (Sigma-Aldrich). For cDNA synthesis a total 
amount of 1 μg of RNA was used. Synthesis of cDNA was performed with the 
RevertAid First Strand cDNA Synthesis kit (ThermoFisher Scientific) according to the 
manufacturer´s protocol. 
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2.2.12.2 Quantitative real-time PCR (qRT-PCR) 
 
Quantitative real-time PCR was performed with the DyNAmo Flash SYBR 
Green qPCR kit (ThermoFisher Scientific). The qRT-PCR was performed in the 
LightCyler480 (Roche). Gene expression of β-actin, Nox4, p21, p53 and TGFβ was 
analyzed by use of specific primer pairs for each gene, respectively. Primers were 
purchased by Sigma-Aldrich. 
 
The composition of each PCR reaction sample was as follows: 
   2 µL cDNA 
   10 µL 2 x qPCR master mix 
   1 µM forward primer 
   1 µM reverse primer 
   6 µL DEPC-treated ddH2O 
   Total volume: 20 µL per reaction 
 
 
 
PCR program: 
1. Initial denaturation   95 °C 10 min 
45 cycles 
2. Denaturation    95 °C 10 sec 
3. Annealing/Extension  60 °C 10 sec 
 
Gene expression for each gene was determined by calculation of the threshold cycle- 
(Ct-) value. The value obtained for each gene was normalized to that of the 
housekeeping gene encoding β-actin. Then the fold change was calculated. 
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2.2.12.3 Primers 
 
β-actin 
 Forward 
 5´-AGACCTGTACGCCAACACAG-3´ 
Reverse 
5´-AGGAGGAGCAATGATCTTG-3´ 
 
Nox4 
Forward 
5´-AGAGCATCTGCATCTGTCCTGAACC-3´ 
Reverse 
5´-AACAATCTTCTTGTTCTCCTGCTAGGGAC-3´ 
 
p21 [113] 
Forward 
5´-AGATCCACAG CGATATCCAGAC-3´ 
Reverse 
5´-ACCGAAGAGACAACGGCACACT-3´ 
 
p53 [114] 
 Forward 
 5´- CTCCGAAGACTGGATGACTGC-3´ 
 Reverse 
 5´- CAACAGATCGTCCATGCAGTG-3´ 
 
TGFβ [115] 
Forward 
5'-GGAGAGCCCTGGATACCAAC-3' 
Reverse 
5'-CAACCCAGGTCCTTCCTAAA-3' 
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2.2.13 Immunofluorescence microscopy 
 
Cryo sections (5 µm) of liver tissue were kindly generated by Gülsah Schwab 
(Heartcenter, University Hospital Cologne). 
 
 
2.2.13.1 TUNEL staining 
 
DNA double-strand breaks were stained using the Click-iT™ Plus TUNEL 
Assay (ThermoFisher Scientific). Sections were fixed and stained according to the 
manufacturer´s protocol (ThermoFisher Scientific). 
 
 
2.2.13.2 MPO and Hoechst staining 
 
 Cryo sections were fixed with 4 % methanol-free formaldehyde for 15 min at 
room temperature (RT), followed by three washing steps with PBS for 5 min at RT. 
Cells were permeabilized with PBS containing 0.1 % Trition X-100 for 20 min at RT. 
Unspecific binding sites were blocked with PBS containing 3 % BSA and 0.1 % Triton 
X-100 for 1 h at RT. Afterwards, MPO was stained using mouse anti-mouse FITC-
conjugated MPO mAb for 1 h at RT. Thereafter, sections were washed thrice with 
PBS in the dark. Nuclei were stained with 1:2000 of 10 mg/mL solution Hoechst 
33342 (ThermoFisher Scientific) for 10 min at RT in the dark. Finally, slides were 
washed three times with PBS in the dark and coverslips were mounted on the 
microscope slides with ProLong™ Gold Antifade Mountant. Sections of the 
preparations were analyzed by confocal laser scanning microscopy. 
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2.2.14 In vivo neutrophil depletion 
 
For neutrophil depletion, mice were intraperitoneally injected with 400 µg anti-
Ly6-G (clone 1A8) Ab in PBS twice, one day prior to LCMV-infection an on day 4 p.i.. 
Control mice did not receive Ab-treatment. Neutrophil depletion was proven by flow 
cytometry via CD11b and Gr-1 staining. Populations of CD11b+/Gr-1hi cells were 
characterized as neutrophils. 
 
 
2.2.15 In vivo MPO inhibition 
 
For MPO inhibition mice were intraperitoneally injected with 25 µg/g body 
weight 4-Aminobenzoic acid hydrazide (4-ABAH) in PBS on the day of LCMV-
infection and every second day until the experimental end. 4-ABAH was diluted to a 
stock concentration of 14 mg/mL in DMSO. Control mice were treated with DMSO in 
PBS alone at the indicated days. 
 
 
2.2.16 Statistical analysis 
 
Data on continuous variables were summarized by mean and standard error of the 
mean (SEM). Groups were compared using independent two-tailed student´s t-test. 
The p-values of p < 0.05, p < 0.01 or p < 0.001 are indicated by *, ** or ***, 
respectively. The numbers of mice per group are indicated in the respective figure 
legends. 
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3 Results 
 
3.1  Effects of MPO-deficiency on LCMV-specific immunopathological 
responses 
 
 LCMV is a non-cytopathic virus. However, it induces robust 
immunopathological reactions depending on the route of infection [116]. During acute 
infection of mice with LCMV, immunopathology is primarily mediated by virus-specific 
CD8+ T cells [117]. 
To assess whether MPO has an influence on immunopathology upon infection with 
LCMV, MPO-deficient (MPO-/-) mice and wt littermates were infected via different 
routes of virus inoculation to analyze the resulting immunopathological syndromes. 
 
 
3.1.1  Influence of MPO on LCMV-induced choriomeningitis 
 
Upon inoculation of LCMV by intracerebral (i.c.) injection, the resulting fatal 
disease is mediated by immune cells, which infiltrate into the brain [118]. The 
immunopathological reaction of wt mice induced by i.c. inoculation of 103 IU of LCMV, 
strain WE, was lethal for 100 % of mice by day 8 p.i. (Fig. 1A). For MPO-/- mice, i.c. 
infection was lethal for all individuals by day 9 p.i.. Over the course of infection, MPO-
/- and wt mice dramatically lost weight from day 5 p.i. on. However, weight loss was 
also comparable in wt and MPO-/- mice (Fig. 1B). 
 
These data indicate that MPO-/- activity is not involved in the lethal outcome of 
immunopathology after i.c. infection of mice with LCMV. 
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A      B 
  
 
Fig. 1  Clinical course of meningitis after i.c. infection with LCMV 
Groups MPO-/- and wt mice were infected by i.c. injection of 103 IU of LCMV, strain WE. (A) 
Survival and (B) body weight of the mice were observed daily. Shown are data from 1 
experiment with n = 5 MPO-/- mice and n = 6 wt mice. Survival p.i. is shown as Kaplan-Meier 
plot.  
 
 
3.1.2  Influence of MPO on LCMV-induced DTH reaction 
 
Subcutaneous (s.c.) intraplantar inoculation of LCMV into the hind footpad of 
mice induces a delayed-type hypersensitivity (DTH) reaction. The immune reaction 
occurs in two distinct phases [98]. CD8+ T cells mediate a first swelling phase, which 
peaks around day 8 p.i.. A second minor swelling phase (days 10 to 16 p.i.) is 
mediated by CD4+ T cells [86]. The LCMV-induced DTH reaction was similar in both 
MPO-/- and wt mice. In both, footpad swelling peaked to a similar extent on day 8 p.i. 
and slowly declined within the following days (Fig. 2). 
 
These data show that the lack of MPO has no influence on the intensity of the LCMV-
induced DTH reaction. This indicates that MPO does not impact the T cell response 
after s.c. intraplantar infection of mice with LCMV. 
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Fig. 2  Influence of MPO on LCMV-specific delayed-type hypersensitivity (DTH) 
reaction 
Groups of MPO-/- and wt mice were infected by s.c. injection with 105 IU LCMV, strain WE, 
into the right hind footpad. On the indicated days p.i., the swelling factor (ratio of the dorso-
ventral thickness of the inoculated foot over that of the non-inoculated foot) was determined. 
Shown are cumulative data as means ±SEM from 2 experiments with n = 13 MPO-/- mice and 
n = 3 wt mice. 
 
 
3.1.3  Course of hepatitis during acute infection of mice with LCMV 
 
Acute hepatitis following intraperitoneal (i.p.) injection of LCMV was 
investigated by determining serum transaminase activity of aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) (Fig. 3). 
In naïve MPO-/- and wt mice, background AST activity was at about 90 U/L. Until day 
4 p.i. background levels were not exceeded in neither MPO-/- nor wt mice. On day 6 
p.i., AST activity increased to about 300 U/L in MPO-/- mice and to 500 U/L in wt 
mice. In wt mice, maximum AST activity was observed at about 2100 U/L on day 8 
p.i., while there was a significant reduction in MPO-/- mice at about 1400 U/L. 
Between days 8 and 10 p.i., AST activity decreased to ranges of about 500 U/L until 
it returned to background levels in both MPO-/- and wt mice by day 14 p.i. (Fig. 3A). 
Similar to AST, ALT activity peaked on day 8 p.i. in MPO-/- and wt mice. In serums of 
MPO-/- mice, ALT activity was about 30 % lower on day 8 p.i. with 500 U/L. In wt 
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mice, the peak reached about 850 U/L. By day 14 p.i., ALT activity decreased to 
background levels of about 40 U/L in both MPO-/- and wt mice (Fig. 3B). 
Hepatic lesions were investigated with hematoxylin and eosin (H&E) staining of liver 
sections on day 8 p.i.. In MPO-/- mice, portal inflammation and interface hepatitis 
were less pronounced than in wt mice (Fig. 4A, B). In addition, necrotic lesions were 
less dense MPO-/- mice (Fig. 4C, D). Fibrosis, i.e. the accumulation of collagen was 
monitored by van Gieson staining, which revealed that fibrosis was absent in both 
MPO-/- and wt mice (Fig. 4E, F). Quantitative histological grading of hepatitis 
according to the Ishak score showed that liver inflammation and damage were 
significantly reduced in MPO-/- mice on day 8 p.i.. In wt mice the Ishak score 
indicated a moderate stage of hepatitis scoring of about 8, while MPO-/- mice had 
only mild signs of hepatitis with a scoring of about 3.5 (Fig. 5). 
CD8+ T cells lyse infected hepatocytes by a perforin- and granzyme B-dependent 
mechanism [90]. This induces a signaling cascade involving cleavage of caspase 3, 
which leads to apoptosis. On day 8 p.i., cleaved caspase 3 was detectable in liver 
homogenates of MPO-/- and wt mice. Similar to the above described observations, 
levels of cleaved caspase 3 in the liver of MPO-/- mice were significantly reduced 
(Fig. 6). 
After acute infection of mice with LCMV, the virus is cleared within 10 to 14 days. 
Virus elimination from the liver and the spleen was analyzed over the course of 
infection. Although liver damage was significantly lower in MPO-/- mice, virus 
elimination from the liver and the spleen was similar in MPO-/- and wt mice over the 
whole course of infection (Fig. 7). 
Together, these data indicate that MPO-deficiency ameliorates the course of 
hepatitis, while virus elimination is not affected. 
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A       B  
 
 
 
 
 
 
 
 
 
Fig. 3  Course of LCMV-induced hepatitis in MPO-/- and wt mice: 
 serum transaminase activity 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Activity of the serum transaminases AST (A) and ALT (B) was measured. Serum samples 
were prepared on the indicated days p.i.. Shown are cumulative data as means ±SEM from 1 
(days 0, 2, 4 and 14), 3 (days 6, 7 and 10) and 9 (day 8) experiments with n = 3 (day 0), n = 
2 (days 2 and 4), n = 7 (day 6), n = 18 (day 7), n = 31 (day 8), n = 12 (day 10) and n = 4 (day 
14) MPO-/- mice and from 1 (days 0, 2, 4 and 14), 2 (days 6 and 10), 3 (day 7) and 7 (day 8) 
experiments with n = 2 (day 0), n = 5 (day 6), n = 14 (day 7), n = 24 (day 8), n = 6 (day 10) 
and n = 3 (day 14) for wt mice. Statistical significance was assessed by Student´s t-test and 
is indicated by * for p≤0.05 
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Fig. 4  H&E and van Gieson staining of liver sections on day 8 p.i. 
 (A, C, E) MPO-/- and (B, D, F) wt mice were infected by i.p. injection of 106 IU of LCMV, 
strain WE. On day 8 p.i., liver samples were prepared and fixed in 4 % PFA. Sections of the 
liver were subjected to standard hematoxylin and eosin (H&E) staining (A, B) arrow heads 
indicate portal inflammation, triangles indicate interface hepatitis. (C, D) focal necrosis. (E, F) 
van Gieson staining. Scale bars: 50 µm (A, B, C, D) or 100 µm (E, F). 
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Fig. 5  Quantification of hepatitis activity according to the Ishak score 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
On day 8 p.i. liver samples were prepared. Liver inflammation was assessed according to the 
Ishak score on micrographs of H&E-stained liver sections. Shown are cumulative data as 
means ±SEM from 2 experiments with n = 6 MPO-/- mice and n = 7 wt mice. Statistical 
significance is indicated by ** for p≤0.01. 
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Fig. 6  Cleaved caspase 3 in the liver of MPO-/- and wt mice on day 8 p.i. 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Cleaved caspase 3 was detected in liver homogenates using specific antibodies by (A) 
Western blot and quantified by (B) densitometry. Shown are cumulative data as means 
±SEM from 2 experiments with n = 3 MPO-/- mice and n = 4 wt mice. Statistical significance is 
indicated by * for p≤0.05 
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A             B  
 
 
 
 
 
 
 
 
 
 
Fig. 7  Course of LCMV-induced hepatitis: viral loads in the liver and the spleen 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Viral loads in (A) liver and (B) spleen as [log10 (PFU/g)] were determined at the indicated 
days p.i.. Shown are cumulative data as means ±SEM from 1 (day 2), 3 (day 4), 3 (day 6), 7 
(day 8) and 3 (day 10) experiments with n = 2 (day 2), n = 6 (days 4, 6), n = 21 (day 8) and n 
= 7 (day 10) for MPO-/- mice and 1 (day 2), 3 (days 4, 6), 6 (day 8) and 2 (day 10) 
experiments with n = 1 (day 2), n = 6 (days 4, 6), n = 17 (day 8) and n = 4 (day 10) for wt 
mice. 
 
 
3.2  The impact of MPO on the CD8+ T cell response during acute LCMV-
induced hepatitis 
 
During acute infection of mice with LCMV, CD8+ T cells are essential for virus 
elimination, however thereby they mediate immunopathology [86, 119]. Thus, the 
ameliorated course of hepatitis in MPO-/- mice suggested that MPO contributes to 
liver damage by influencing the effector functions of CD8+ T cells. 
 
 
3.2.1  Influence of MPO on T cell expansion in the spleen  
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(days 0 to 10 p.i.), T cell expansion in the spleen was analyzed by flow cytometry. 
Among the lymphatic cells in the spleen of naïve mice, about 10 % were CD8+ T cells 
(Fig. 8A). These percentages did not change until day 6 p.i.. On day 8 p.i., 
percentages of about 25 % were reached, in both MPO-/- and wt mice. By day 10 p.i., 
the percentages dropped to about 15 % in MPO-/- and wt mice. Over the whole 
course of infection, CD8+ T cell frequencies were similar in MPO-/- and wt mice. 
During acute infection with LCMV, CD4+ T cells also proliferate and contribute to the 
anti-viral immune response [117]. Over the whole course of infection, the frequencies 
of CD4+ T cells among the lymphatic cells in the spleen were similar in both, MPO-/- 
and wt mice (Fig. 8B). 
 
 
A         B 
 
 
 
 
 
 
 
 
 
Fig. 8  Kinetics of splenic CD8+ and CD4+ T cells during acute LCMV-induced hepatitis 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
Percentages of (A) CD8+ and (B) CD4+ T cells among lymphatic spleen cells were 
determined by flow cytometry. Shown are cumulative data as means ±SEM from 2 (day 0), 1 
(day 2), 3 (day 4, 6), 6 (day 8) and 1 (day 10) experiments with n = 4 (day 0), n = 2 (days 2, 
10), n = 6 (day 4, 6) and n = 16 (day 8) MPO-/- mice and from 2 (day 0), 1 (day 2), 3 (day 4), 
2 (day 6), 6 (day 8) and 1 (day 10) experiments with n = 4 (day 0), n = 2 (days 2, 6, 10) and n 
= 15 (day 8) wt mice. 
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3.2.2  The impact of MPO on the effector functions of T cells in the spleen 
 
To investigate, whether MPO has an influence on the effector functions of 
CD8+ T cells, the virus-specific cytotoxic activity of these cells was analyzed ex vivo. 
In wt mice, the cytotoxic activity of CD8+ T cells usually peaks on day 8 p.i. [121]. 
Specific lysis by total splenocytes as effector cells from both MPO-/- and wt mice was 
about 20 % at an effector:target ratio of 100:1, on day 8 p.i. (Fig. 9A). To assess the 
cytotoxic activity of CD8+ spleen cells without any possible interference of other 
spleen cells, CD8+ T cells were immunomagnetically enriched to purities of >95 %. 
Specific lysis of LCMV-infected target cells by these enriched CD8+ T cells reached 
about 40 % at an effector:target ratio of 100:1, for both MPO-/- and wt mice on day 8 
p.i. (Fig. 9B). 
Antigen-specific target cell killing in vitro depends on the frequency of LCMV-specific 
CD8+ T cells among CD8+ splenocytes. The frequencies of LCMV-specific CD8+ T 
cells were assessed by flow cytometry using dextramers loaded with either of the 
three H-2Db-restricted immunodominant epitopes of LCMV, GP33-41, GP276-286 and 
NP396-404. On day 8 p.i., about 20 % of CD8
+ spleen cells expressed LCMV-specific T 
cell receptors (TCRs) for these three epitopes (TCRLCMV
+) in both, MPO-/- and wt 
mice (Fig. 9C).  
Mature LCMV-specific CD8+ T cells secrete IFNγ upon antigen recognition. Following 
4 h in vitro stimulation with non-infected or LCMV-infected fibroblasts, splenic CD8+ T 
cells were analyzed for intracellular accumulation of IFNγ by flow cytometry on day 8 
p.i.. Upon stimulation with non-infected fibroblasts, about 1 % of CD8+ T cells 
expressed IFNγ in both MPO-/- and wt mice (Fig. 10). 
After stimulation with LCMV-infected fibroblasts, the frequencies of CD8+ T cells 
expressing IFNγ reached about 2 % in MPO-/- and wt mice. 
Altogether, the percentages of CD4+ and CD8+ T cells, the cytotoxic activity, as well 
as the frequencies of virus-specific CD8+ T cells and intracellular accumulation of 
IFNγ were similar in MPO-/- and wt mice. This is surprising, because in MPO-/- mice 
significantly lower serum levels of transaminases were detected over the course of 
LCMV infection. It is well established that this hepatic destruction is mainly mediated 
by CD8+ T cells. This raised the question about the MPO-dependent mechanism 
                                                                                                                         3 Results 
42 
 
mediating immunopathology, which does not affect the generation of a virus-specific 
CD8+ T cell response. 
 
 
A     B      C 
 
 
 
 
 
 
 
 
Fig. 9  Cytotoxic activity of splenic CD8+ T cells on day 8 p.i.. 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
At day 8 p.i. LCMV-specific cytotoxic activity of (A) total spleen cells or (B) 
immunomagnetically enriched CD8+ effector cells (purity >95 %) against LCMV-infected 
syngeneic fibroblasts was determined by 4 h [51Cr]-release assay. Cytotoxic activity is 
shown as mean ±SEM from 3 experiments with n = 7 MPO-/- and n = 8 wt mice. (C) 
Percentages of LCMV-specific CD8+ T cells were determined by flow cytometry using MHC 
dextramers loaded with LCMV-specific epitopes (MHC I alleles and epitopes: H-2Db-
restricted immunodominant epitopes GP33-41, GP276-286, and NP396-404). From these data, the 
frequencies of LCMV-specific CD8+ T cells were calculated as follows: % TCRLCMV
+ CD8+ 
cells / % CD8+ spleen cells x 100 %. Columns show cumulative data of the frequencies of 
LCMV-specific CD8+ spleen cells as means ±SEM from 8 experiments with n = 24 MPO-/- 
mice and n = 24 wt mice. 
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Fig. 10 IFNγ accumulation in splenic CD8+ T cells after stimulation with LCMV-infected 
fibroblasts 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
On day 8 p.i., accumulation of intracellular IFNγ in immunomagnetically enriched CD8+ 
effector cells upon 4 h co-culture with non-infected or LCMV-infected syngeneic fibroblasts 
was determined by flow cytometry. Frequencies of IFNγ+/CD8+ T cells are shown as mean 
±SEM from 1 experiment with n = 3 MPO-/- and n = 3 wt mice. 
 
 
3.2.3  Influence of MPO on T cell infiltration in the liver during acute LCMV-
induced hepatitis 
 
The immune response of splenic CD8+ T cells was not altered in MPO-/- mice. 
However, deficiency in MPO has a strong impact on LCMV-induced liver-specific 
immunopathology. Therefore, the presence and activity of LCMV-induced T cells in 
the liver was characterized. 
After virus-specific induction and expansion, T cells infiltrate in the liver during acute 
LCMV-mediated hepatitis [99, 122]. To investigate, whether the milder course of 
hepatitis in MPO-/- mice was due to reduced T cell infiltration, frequencies of CD8+ 
and CD4+ T cells in the liver were analyzed by flow cytometry (Fig.11). 
Low percentages of about 2 % CD8+ T cells were detectable among leukocytes in the 
liver of naïve mice (Fig 11A). In both, MPO-/- and wt mice, percentages increased by 
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day 6 p.i. to about 40 % CD8+ T cells among lymphatic leukocytes. On day 8 p.i., 
CD8+ T cell frequencies in the liver peaked at about 50 % in MPO-/- and wt mice. 
Over the whole course of infection (days 0 to 10 p.i.) the frequencies of CD8+ T cells 
were similar in both, MPO-/- and wt mice. 
In naïve MPO-/- and wt mice, about 4 % of leukocytes in the liver were CD4+ T cells. 
Over the course of infection, the frequencies of CD4+ T cells in the liver stayed in a 
range of 4-6 % in both, MPO-/- and wt mice (Fig 11B). 
 
 
A          B  
 
 
 
 
 
 
 
 
 
Fig. 11 Kinetics of hepatic CD8+ and CD4+ T cells during acute LCMV-induced hepatitis 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
In the perfused liver, percentages of (A) CD8+ and (B) CD4+ T cells among leukocytes were 
determined by flow cytometry. Shown are cumulative data as means ±SEM from 2 (day 0), 3 
(day 4), 1 (days 6 and 10) and 4 (day 8) experiments with n = 4 (day 0), n = 5 (day 4) n = 2 
(days 6 and 10) and n = 9 (day 8) MPO-/- mice and from 2 (day 0), 3 (day 4), 1 (days 6 and 
10), 4 (day 8) experiments with n = 4 (day 0), n = 5 (day 4), n = 2 (days 6 and 10) and n = 10 
(day 8) wt mice. 
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3.2.4  The impact of MPO on the cytotoxic activity of liver-infiltrating CD8+ T 
cells 
 
The LCMV-specific response of liver-infiltrating CD8+ T cells from MPO-/- and 
wt mice was characterized by measuring the cytotoxic activity ex vivo. 
In wt mice, serum transaminase levels peaked on day 8 p.i. and correlated with the 
course of the immune response of CD8+ T cells. Serum AST activity in MPO-/- mice 
was already reduced on day 7 p.i.. Therefore, the cytotoxic activity of liver-infiltrating 
CD8+ T cells was analyzed on days 7 and 8 p.i.. 
On day 7 p.i., enriched CD8+ T cells from the liver of either MPO-/- or wt mice already 
exerted a strong LCMV-specific cytolysis of about 60 % at an effector:target ratio of 
100:1 (Fig. 12A). On day 8 p.i., the cytotoxic activity of liver-infiltrating CD8+ T cells 
was further enhanced to about 70 % at an effector:target ratio of 100:1 (Fig. 12B). 
Virus-specific CD8+ T cells from MPO-/- and wt mice exerted similar specific lysis on 
days 7 and 8 p.i.. 
The frequencies of virus-specific CD8+ T cells were analyzed by flow cytometry using 
dextramers loaded with either of the three H-2Db-restricted immunodominant 
epitopes of LCMV. On day 7 p.i., about 30 % of liver-infiltrating CD8+ T cells 
expressed TCRLCMV
+ among the lymphatic cells in MPO-/- and wt mice (Fig. 13). 
On day 8 p.i., about 34 % of liver-infiltrating CD8+ T cells in MPO-/- mice and 28 % in 
wt mice expressed TCRLCMV
+. This difference was not significant. 
Activated CTLs produce IFNγ as long as TCR stimulation persists (reviewed in [89, 
123]). Because of that, IFNγ accumulation in immunomagnetically enriched liver-
infiltrating CD8+ T cells was assessed by flow cytometry after 4 h in vitro stimulation 
with non-infected or LCMV-infected syngeneic fibroblasts on day 8 p.i. (Fig.14).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
After stimulation of liver-infiltrating CD8+ T cells with non-infected fibroblasts, about 4 
% expressed IFNγ in both MPO-/- and wt mice. After stimulation with LCMV-infected 
fibroblasts about 10 % of CD8+ T cells responded with IFNγ production. In both, 
MPO-/- and wt mice, the frequencies of IFNγ-expressing liver-infiltrating CD8+ T cells 
were similar. 
In line with the results for splenic CD8+ T cells, the cytotoxic activity and the 
frequencies of liver-infiltrating CD8+ T cells expressing TCRLCMV
+ were similar in 
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MPO-/- and wt mice. MPO did not alter the response of CD8+ T cells in the liver 
neither on day 7 p.i. nor on day 8 p.i.. 
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Fig. 12 Cytotoxic activity of liver-infiltrating CD8+ T cells on days 7 and 8 p.i. 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
At days (A) 7 and (B) 8 p.i. LCMV-specific cytotoxic activity of immunomagnetically enriched 
CD8+ effector cells from the liver (purity >95 %) against LCMV-infected syngeneic fibroblasts 
was determined by 4 h [51Cr]-release assays. Cytotoxic activity is shown as mean ±SEM 
from 1 experiment with n = 2 MPO-/- mice and n = 2 wt mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13 Frequencies of liver-infiltrating, LCMV-specific CD8+ T cells on days 7 and 8 p.i. 
-Legend continued on next page- 
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-Continued legend- 
Fig. 13 Frequencies of liver-infiltrating, LCMV-specific CD8+ T cells on days 7 and 8 p.i. 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
At days (A) 7 and (B) 8 p.i. percentages of LCMV-specific CD8+ T cells were determined by 
flow cytometry with MHC dextramers loaded with LCMV-specific epitopes (MHC I alleles and 
epitopes: H-2Db-restricted immunodominant epitopes GP33-41, GP276-286, and NP396-404). From 
these data, the frequencies of LCMV-specific CD8+ T cells were calculated as follows: % 
TCRLCMV
+ CD8+ cells / % CD8+ liver cells x 100 %. Column diagrams show cumulative data of 
the frequencies of LCMV-specific CD8+ leukocytes as means ±SEM from 1 (day 7) and 4 
experiments (day 8) with n = 2 (day 7) and n = 10 (day 8) MPO-/- and wt mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14 IFNγ accumulation in liver-infiltrating CD8+ T cells after stimulation with   
LCMV-infected fibroblasts 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
At day 8 p.i., accumulation of intracellular IFNγ by immunomagnetically enriched CD8+ 
effector cells upon 4 h co-culture with non-infected or LCMV-infected syngeneic fibroblasts 
was determined by flow cytometry. Frequencies of IFNγ+/CD8+ T cells are shown as mean 
±SEM from 1 experiment with n = 3 MPO-/- and n = 3 wt mice. 
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3.3  Myeloid cells and LCMV-induced acute hepatitis 
 
Immunopathology during LCMV-induced hepatitis is largely mediated by CD8+ 
T cells. However in MPO-/- mice, the immune response of CD8+ T cells was not 
altered over the course of infection. Due to that, we wanted to elucidate, to what 
extent myeloid cells contribute to liver injury. 
 
 
3.3.1  Myeloid cells in the liver during LCMV-induced acute hepatitis 
 
The recruitment of myeloid cells to the liver was analyzed in naïve mice and on 
day 8 p.i. by flow cytometry (Fig. 15, 16). 
In naïve MPO-/- and wt mice, frequencies of neutrophils (CD11b+/Ly6Ghi) among 
leukocytes in the liver were below 3 % (Fig. 15A, 16A) [124]. On day 8 p.i., 
frequencies increased to about 9 % in MPO-/- mice. In wt mice, percentages of 
neutrophils were slightly, but significantly lower with about 7 %. Infiltrating monocytes 
as identified by CD11b+/Ly6Chi expression reached about 4 % of leukocytes in naïve 
MPO-/- and wt mice (Fig. 15B, 16B) [125]. On day 8 p.i., about 18 % of liver 
leukocytes were infiltrating monocytes in both, MPO-/- and wt mice. Infiltrating 
macrophages can be distinguished from Kupffer cells (KCs), which are resident liver 
macrophages, by low expression of F4/80 (CD11b+/F4/80low), while KCs have high 
expression of F4/80 (CD11b+/F4/80hi) [126]. In naïve MPO-/- and wt mice, 
percentages of CD11b+/F4/80low macrophages were about 0.5 % (Fig. 15C, 16C). 
The frequencies of infiltrating macrophages increased to about 10 % in MPO-/- mice 
and to about 8 % in wt mice on day 8 p.i.. This difference was not significant. In naïve 
MPO-/- and wt mice KCs were present in the range of 11-14 % (Fig. 15D, 16D). On 
day 8 p.i., frequencies of KCs were not altered with about 14 % in both MPO-/- and wt 
mice. 
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Fig. 15 FACS strategy for the identification of myeloid cells in the liver 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
Single cell suspensions of the perfused liver were prepared on the indicated days and 
percentages of (A) neutrophils (CD11b+/Ly6Ghi), (B) monocytes (CD11b+/Ly6Chi), (C) 
macrophages (CD11b+/F4/80+) and (D) Kupffer cells (CD11b+/F4/80hi) among liver 
leukocytes were determined by flow cytometry. Shown are representative FACS Plots of wt 
mice from day 8 p.i.. 
CD11b
 
Ly6G
 
Neutrophils 
CD11b
 
Ly6C
 
Monocytes 
CD11b
 
F4/80
 
Macrophages 
CD11b
 
F4/80
 
Kupffer cells 
                                                                                                                         3 Results 
50 
 
A   B    C     D 
 
 
 
 
 
 
 
 
 
Fig. 16 Recruitment of myeloid cells to the liver during LCMV-induced hepatitis 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
Single cell suspensions of the perfused liver were prepared on the indicated days and 
percentages of (A) neutrophils (CD11b+/Ly6Ghi), (B) monocytes (CD11b+/Ly6Chi), (C) 
macrophages (CD11b+/F4/80+) and (D) Kupffer cells (CD11b+/F4/80hi) among liver 
leukocytes were determined by flow cytometry. Shown are cumulative data as means ±SEM 
from 3 (day 0) and 5 (day 8) experiments with n = 5 (day 0) and n = 10 (day 8) MPO-/- and wt 
mice for neutrophils. 1 (day 0) and 2 (day 8) experiments with n = 2 (day 0) and n = 5 MPO-/- 
and wt mice for monocytes, macrophages and Kupffer cells. Statistical significance is 
indicated by * for p≤0.05. 
 
 
3.3.2  Cell type-specific expression of MPO 
 
MPO is predominantly located in primary granules of neutrophils [127]. In 
humans, MPO is expressed to a lesser extent by monocytes and macrophage 
subsets [128-130]. In rodents, little is known about MPO expression in myeloid cells, 
except for neutrophils [5]. 
MPO expression by neutrophils (CD11b+/Ly6Ghi), monocytes (CD11b+/Ly6Chi), 
infiltrating macrophages (CD11b+/F4/80low/+) and KCs (CD11b+/F4/80hi) in the liver 
was assessed on day 8 p.i. according to FACS strategy in 3.3.1 (Fig. 15). Mean 
fluorescence intensity (MFI) of MPO expression was determined by substraction of 
cell type-specific autofluorescence from measurements of specifically stained 
samples (Fig. 17). In MPO-/- mice, MPO expression was absent in each neutrophils, 
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monocytes, macrophages or KCs. Among myeloid cells in the liver of wt mice, only 
neutrophils expressed high amounts of MPO (Fig. 17A). Monocytes and infiltrating 
macrophages contained very low levels of MPO (Fig. 17 B, C). MPO detection in 
monocytes and macrophages is not necessarily due to cell type-specific expression. 
Instead, phagocytosed contents of neutrophils may contain immunoreactive MPO 
during inflammation [131]. In KCs from wt mice MPO was not detectable (Fig. 17D). 
Taken together, these data indicate that among myeloid cells, neutrophils are the 
main source of MPO during LCMV-induced infection, in wt mice. 
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Fig. 17 Cell type-specific expression of MPO by myeloid cells in the liver 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
Single cell suspensions of the perfused liver were prepared on day 8 p.i. and gating strategy 
was assessed according to cell appearance in the FSC/SSC and surface marker staining 
according to FACS strategy in 3.3.1 Fig. 15. Expression of intracellular MPO by (A) 
neutrophils (CD11b+/Ly6Ghi), (B) monocytes (CD11b+/Ly6C+), (C) macrophages 
(CD11b+/F4/80+) and (D) Kupffer cells (CD11b+/F4/80hi) was determined by flow cytometry. 
Intracellular expression of MPO is shown as means of mean fluorescence intensity (MFI) 
minus autofluorescence as ±SEM from 1 experiment with n = 2 MPO-/- mice and n = 2 wt 
mice. 
 
 
3.3.3  Neutrophil recruitment to the liver over the course of LCMV infection 
 
Neutrophils expressed the highest amounts of MPO in wt mice. Furthermore, 
frequencies of neutrophils were increased on day 8 p.i., in both MPO-/- and wt mice 
(Fig. 16A). Therefore, neutrophil infiltration in the liver over the whole course of 
infection was analyzed. 
In naïve mice, as well as on days 2 and 4 p.i., less than 3 % among leukocytes in the 
liver amounted to neutrophils of both, MPO-/- and wt mice (Fig. 18). On day 6 p.i., 
frequencies increased to about 5-6 % in both genotypes. On day 8 p.i., about 8.5 % 
among leukocytes in the liver of MPO-/- mice were neutrophils. In wt mice, slightly, 
but significantly lower frequencies of about 6.5 % were detected. On day 10 p.i., 
percentages declined to about 5 % in MPO-/- and wt mice. 
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Together, these data show that neutrophil recruitment to the liver peaks on day 8 p.i. 
and declines afterwards. These kinetics correlate with the course of both, serum AST 
levels and infiltration of CD8+ T cells in the liver. This is surprising, since neutrophils 
are known to be first-line defenders against invading pathogens, which are recruited 
shortly after infection [41]. However, here neutrophil infiltration in the liver parallels 
the course of the adaptive immune response against LCMV.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18 Neutrophil recruitment to the liver over the course of LCMV infection 
Groups of MPO-/- and wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
In the perfused liver, percentages of neutrophils (CD11b+/Ly6Ghi) among leukocytes were 
determined by flow cytometry. Shown are cumulative data as means ±SEM from 3 (days 0 
and 4), 1 (days 2 and 10), 5 (day 8) and 4 (day 8) experiments with n = 5 (days 0 and 4), n = 
1 (day 2) n = 5 (day 4) and n = 3 (day 6), n = 10 (day8) and n = 2 (day 10) MPO-/- and wt 
mice. Statistical significance is indicated by * for p≤0.05. 
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3.3.4  LCMV-induced hepatitis in mice depleted of neutrophils 
 
The kinetics of neutrophil recruitment to the liver correlated with the course of 
liver damage during LCMV-induced hepatitis. To assess the functional role of 
neutrophils in viral hepatitis, neutrophils were depleted in LCMV-infected wt mice with 
anti-Ly6G (clone 1A8) antibody at the day of infection and four days after infection. 
Neutrophils can be easily detected by Ly6G staining. However the depletion antibody 
is directed against Ly6G also. This means that false negative flow cytometry may be 
due to masking of the epitope Ly6G by the depletion antibody instead of successful 
elimination of neutrophils. Therefore, neutrophil depletion was assessed by flow 
cytometry of CD11b+/Gr-1hi cells (Fig. 19A) [132]. 
To test whether antibody treatment itself causes liver damage, serum AST activity in 
naïve mice was measured one day after antibody injection (Fig. 19B). In comparison 
to untreated naïve mice, antibody treatment did not increase AST levels in serum of 
non-infected mice. Background AST activity was at about 90 U/L in both groups. 
On days 7 and 8 p.i., AST activity was at about 1000 U/L in control mice, while in 
mice depleted of neutrophils, AST activity was highly significantly increased to about 
3000 U/L on both days (Fig. 19B). 
In comparison to control mice, viral loads in the liver and the spleen of neutrophil-
depleted mice were slightly increased on days 1 and 2 p.i. (Fig. 20). However, on day 
8 p.i., viral load in the liver and the spleen was significantly higher, in mice depleted 
of neutrophils. 
This was surprising, since neutrophils are the main cell type expressing MPO. In our 
model, we could show that MPO is involved in aggravated tissue damage. Therefore, 
we hypothesized that neutrophil depletion would reduce liver damage in wt mice. 
However, a recent publication by Liang et al. revealed that the response of CD8+ T 
cell is partially controlled by immunosuppressive neutrophils [133]. This means that 
neutrophils can be involved in minimizing tissue damage by suppressing a strong 
CTL response.  
These data add up to a paradoxical constellation. On the one hand, neutrophils are 
involved in limiting LCMV-induced immunopathology. On the other hand, MPO 
largely expressed by neutrophils, contributes to LCMV-induced liver damage. 
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Fig. 19 Neutrophil depletion aggravates liver damage in mice infected with LCMV 
Groups of Bl/6J wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Neutrophils were depleted by i.p. injection of 400 µg anti-mouse Ly6G, clone 1A8. Control 
mice did not receive antibody treatment. (A) Neutrophil depletion in the liver was confirmed 
by CD11b and Gr-1 staining. Plots show representative examples of CD11b+/Gr-1hi staining. 
(B) Activity of the serum transaminase AST was measured. Serum samples were prepared 
on the indicated days p.i.. Shown are cumulative data as means ±SEM from 1 (naïve) and 2 
(days 7 and 8) experiments with n = 3 (naïve) and n = 7 (days 7 and 8) mice per group. 
Statistical significance was assessed by Student´s t-test and is indicated by ** for p≤0.01 and 
*** for p≤0.001. 
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Fig. 20 Viral loads in the liver and the spleen after depletion of neutrophils 
Groups of Bl/6J wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Neutrophils were depleted by i.p. injection of 400 µg anti-mouse Ly6G, clone 1A8. Control 
mice did not receive antibody treatment. Viral loads in (A) liver and (B) spleen as [log10 
(PFU/g)] were determined at the indicated days p.i.. Shown are cumulative data as means 
±SEM from 1 (days 1 and 2) and 2 (day 8) experiments with n = 2 (days 1 and 2), n = 8 (day 
8) mice per group. Statistical significance was assessed by Student´s t-test and is indicated 
by * for p≤0.05 and ** for p≤0.01. 
 
 
3.4  The impact of MPO on neutrophil defense mechanisms in response to 
LCMV infection 
 
Neutrophils are involved in the primary defense against infections by three 
major mechanisms, i.e. phagocytosis, degranulation and NETosis (reviewed in [41]).  
During these processes, pathogens are exposed to MPO-derived ROS. 
We wanted to elucidate, whether MPO-induced immunopathology during acute 
LCMV infection can be attributed to these defense mechanisms. 
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3.4.1  The impact of intracellular MPO activity on LCMV-induced 
immunopathology 
 
For the generation of hypohalous acids, MPO uses hydrogen peroxide 
produced by various ROS sources, e.g. NADPH oxidases (NOX) [10, 134, 135]. In 
neutrophils, intracellular ROS are predominantly produced by NOX2 [136]. Thus, 
particularly intracellular MPO activity, which contributes to microbial killing upon 
phagocytosis, is dependent on NOX2 [44].  
Therefore, we studied mice with NOX2-deficiency in myeloid cells (NOX2flox/flox x 
LysM Crepos). In these mice, cells of the myeloid lineage i.e. granulocytes, monocytes 
and macrophages produce much lower amounts of ROS than wt cells [137, 138]. 
This potentially causes reduced intracellular levels of MPO-derived oxidants in 
neutrophils. 
LCMV-induced liver damage was assessed by serum AST levels over the course of 
infection (Fig. 21A). On day 6 p.i., AST activity was at about 500 U/L in NOX2flox/flox x 
LysM Crepos and NOX2flox/flox x LysM Creneg mice. On days 7 and 8, AST activity 
increased to about 1500 U/L and declined to about 700 U/L by day 10 p.i. in both, 
NOX2flox/flox x LysM Crepos and NOX2flox/flox x LysM Creneg mice. Over the whole 
course of infection, AST activity was similar in NOX2flox/flox x LysM Crepos and 
NOX2flox/flox x LysM Creneg mice. Virus elimination from the liver and the spleen was 
also unaffected by NOX2-deficiency in myeloid cells (Fig. 21B, C) 
These data show that LCMV-induced immunopathology is independent of NOX2 
expression in myeloid cells. Since intracellular MPO requires hydrogen peroxide 
predominantly generated by NOX2, this suggests that immunopathology and virus 
elimination are largely independent on intracellular MPO activity in neutrophils. 
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Fig. 21 Serum AST activity and viral loads in NOX2flox/flox x LysM Cre mice 
Groups of NOX2flox/flox x LysM Crepos and NOX2flox/flox x LysM Creneg mice were infected by i.p. 
injection of 106 IU of LCMV, strain WE. (A) Activity of the transaminase AST was measured 
in serum samples, which were prepared on the indicated days p.i.. Shown are cumulative 
data as means ±SEM from 2 (days 6 and 10), 4 (days 7) and 5 (day 8) experiments with n = 
8 (day 6), n = 15 (day 7), n = 13 (day 8), n = 10 (day 10) NOX2flox/flox x LysM Crepos and from 
2 (day 6), 4 (day 7), 7 (day 8) and 3 (day 10) experiments with n = 6 (day 6), n = 12 (day 7), 
n = 15 (day 8), n = 7 (day 10) NOX2flox/flox x LysM Creneg mice. Viral load in (B) the liver and 
(C) the spleen as [log10 (PFU/g)] were determined at the indicated days p.i.. Shown are 
cumulative data as means ±SEM from 4 (days 7 and 8) and 1 experiment with n=15 (day 7) 
n=11 (day 8) and n=3 (day 10) NOX2flox/flox x LysM Crepos mice and n=12 (days 7 and 8) and 
n=3 (day 10) NOX2flox/flox x LysM Creneg mice. 
 
 
3.4.2  Neutrophil extracellular trap formation by MPO-/- neutrophils 
 
 NETs are web-like chromatin structures, which are released by neutrophils in 
response to various stimuli (reviewed in [46]). NET-induced inactivation of various 
pathogens is, among other factors, dependent on MPO (reviewed in [42, 139, 140]).  
Besides pathogen clearance, excessive NET formation can aggravate tissue damage 
(reviewed in[46]). We wanted to investigate, if LCMV stimulates NET formation by 
neutrophils, which possibly may contribute to immunopathology. 
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To investigate NETosis in response to LCMV, neutrophils were enriched from the 
bone marrow of naïve MPO-/- and wt mice. NETosis was assessed after 4 h in vitro 
incubation with PMA or LCMV [141]. As a surrogate indicator of NETosis, 
extracellular DNA was stained with the plasma membrane-impermeable dye SYTOX 
Green and analyzed by flow cytometry (Fig. 22). Sytox greenpos neutrophils after 
stimulation with 25 nM PMA are shown in representative FACS plots to introduce the 
gating strategy (Fig. 22A).  
About 3.5 % of unstimulated neutrophils from MPO-/- mice and 2 % from wt mice 
released DNA spontaneously (Fig. 22B). When neutrophils were exposed to 25 nM 
PMA, about 12 % of cells were SYTOX Greenpos from both MPO-/- and wt mice. Upon 
exposure to LCMV at either MOI 10 or MOI 100, about 10 % of neutrophils from 
MPO-/- mice and about 8 % from wt mice were SYTOX Greenpos. Under consideration 
of the level of spontaneous NETosis in both genotypes, this difference was not 
significant. 
This in vitro study reveals that stimulation of neutrophils with high MOI of LCMV 
induces NETosis by murine neutrophils. However, this process is independent of 
MPO. With the observations from mice with NOX2-deficiency in cells of the myeloid 
lineage, these data suggest that immunopathology does not depend on the activity or 
presence of intracellular MPO. Even in the absence of the major source of 
intracellular hydrogen peroxide, NOX2, LCMV-induced immunopathology was 
unaltered and NETosis in response to LCMV was independent of MPO. 
Together, these data imply that LCMV-induced immunopathology is independent of 
intracellular MPO activity. Instead, it may be caused by extracellular MPO, which 
retains its activity by consumption of ROS from various undefined sources. 
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Fig. 22 NET formation by murine neutrophils in response to stimulation with LCMV 
Neutrophils were negatively enriched from the bone marrow from groups of naïve MPO-/- and 
wt mice. Upon 4 h in vitro cultivation, extracellular DNA released by unstimulated cells or 
after incubation with 25 nM PMA, MOI 10 or MOI 100 LCMV was stained with plasma 
membrane-impermeable dye SYTOX green. (A) Shown are representative FACS plots of 
neutrophils stimulated with 25 nM PMA. (B) Shown are % SYTOX Greenpos cells as mean 
±SEM from 1 experiment with n = 2 MPO-/- and wt mice. 
 
 
3.5  Cytotoxic effects of MPO in the liver 
 
By in vivo depletion of neutrophils, we observed that neutrophils seem to be 
involved in limiting immunopathology in the liver. In parallel, MPO is expressed 
exclusively by neutrophils and contributes to liver injury during LCMV-induced 
hepatitis. Extracellular MPO itself may directly contribute to tissue damage, especially 
under inflammatory conditions [44, 142]. In this context, we wanted to elucidate the 
cytotoxic effects of MPO on hepatocytes. 
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3.5.1  Cytotoxicity of MPO against hepatocytes 
 
MPO concentrations in the plasma and in liver lysates of wt mice were 
determined over the course of LCMV infection. 
Systemic levels of extracellular MPO in the plasma increased from background levels 
of about 15 ng/mL in naïve mice to about 60 ng/mL on day 2 p.i. (Fig. 23A). By day 4 
p.i., MPO levels slightly declined to 30 ng/mL. Remarkably, on day 8 p.i., when liver 
damage peaks, MPO plasma levels were strongly increased to 150 ng/mL. 
In liver lysates, total levels of MPO did not exceed background levels of about 20 
pg/µg of total protein during the first four days after infection (Fig 23B). Similarly to 
systemic levels, the concentration of MPO in the liver increased to about 100 pg/µg 
by day 8 p.i.. 
To test the direct cytotoxicity of MPO, death of primary hepatocytes was quantified in 
the presence of MPO and the H2O2-donor glucose oxidase (GOX) in vitro. After 4 h 
incubation of freshly prepared hepatocytes from naïve wt mice with concentrations of 
0.1 U/mL or 1.0 U/mL enzymatically active MPO, cell death was assessed by flow 
cytometry of Propidium iodide-positive (PIpos) cells minus spontaneous cell death of 
untreated hepatocytes (Fig. 24). GOX generates H2O2, which is cytotoxic itself. 
About 9 % of hepatocytes were PIpos after 4 h incubation with GOX alone. MPO 
without additional GOX was barely cytotoxic for hepatocytes. In the presence of GOX 
and 0.1 U/mL MPO, about 10 % among hepatocytes were PIpos. GOX and 1.0 U/mL 
MPO induced cell death of about 17 % of hepatocytes after 4 h incubation. 
Together, these data suggest that there is a correlation between MPO concentration 
and MPO-induced hepatocyte death in vitro and in vivo. 
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A      B 
            
 
 
 
 
 
 
 
 
Fig. 23 MPO concentration in the plasma and in liver lysates over the course of LCMV 
infection 
Groups of Bl/6J wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. 
Protein concentrations of extracellular MPO in the (A) plasma and total MPO in (B) liver 
lysates were determined by MPO-specific ELISA. Plasma and liver samples were prepared 
on the indicated days from naïve and infected mice. Shown are MPO concentrations as 
±SEM from 1 experiment with n = 3 (days 0, 4 and 8), n = 2 (days 1 and 2) wt mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24 MPO-induced hepatocyte death in vitro  
Murine primary hepatocytes were incubated for 4 h with 0.1 U/mL GOX, 0.1 U/mL MPO or 
1.0 U/mL MPO alone, or with combinations of GOX and MPO. Controls were left untreated. 
Cell death was quantified by flow cytometry of PIpos hepatocytes. Shown are means of % 
PIpos cells beyond spontaneous cell death. Means ±SEM of n=3 wt mice. 
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3.5.2  Co-localization of apoptotic hepatocytes with MPO in vivo 
 
The abovementioned in vitro setup does not reflect physiological conditions. 
Therefore, we investigated, whether apoptotic hepatocytes co-localized with MPO or 
MPO-expressing cells in vivo. For that purpose, co-localization of apoptotic 
(TUNELpos) hepatocytes and MPO was analyzed by immunofluorescence microscopy 
of liver sections from naïve and LCMV-infected wt mice. In naïve wt mice, 
spontaneous cell death was almost absent. On the sections only very few cells were 
TUNELpos (Fig. 25A). Additionally, none among TUNELpos cells co-localized with 
MPO in naïve mice (Fig. 25B, C). On day 8 p.i., about 7 % of cells per visual field 
were TUNELpos (Fig. 25B). Among MPOpos events per visual field, about 27 % of 
cells were positively stained for TUNEL, on day 8 p.i. (Fig. 25C). 
In conclusion, MPO concentration in the plasma and the liver coincide with the peak 
of liver damage and neutrophil infiltration on day 8 p.i.. In line with this, on day 8 p.i., 
apoptotic hepatocytes partially co-localize with MPO. Additionally, MPO induces 
hepatocyte death in vitro in a concentration-dependent manner. Together, these data 
suggest a correlation of liver damage with the total MPO concentration and neutrophil 
frequencies during LCMV-induced hepatitis. 
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   B   C 
 
 
 
 
 
 
 
 
 
Fig. 25 Co-localization of apoptotic hepatocytes with MPO 
Groups of Bl/6J wt mice were infected by i.p. injection with 106 IU of LCMV, strain WE. (A) 
Cryo sections (6 µm) of liver samples from naïve and infected mice were analyzed for DNA 
fragmentation via TUNEL staining and MPO expression using specific Ab by 
immunofluorescence microscopy. Representative micrographs are shown. (B) Total cell 
number in nine visual fields per sample was counted and the percentage of TUNELpos cells in 
% among total cells was calculated. Shown are % of TUNELpos cells as mean ±SEM of n=3 
wt naïve and d8 p.i. mice. (C) Percentage of TUNELpos cells among MPOpos events was 
calculated. Shown are % of TUNELpos/MPOpos cells as mean ±SEM of n=3 wt naïve and d8 
p.i. mice. 
 
 
3.5.3  In vivo inhibition of extracellular MPO 
 
Extracellularly added MPO in combination with a H2O2-donor induced 
hepatocyte death in vitro. Furthermore, histology revealed that apoptotic hepatocytes 
partially co-localize with MPO. In contrast, liver damage was not altered in NOX2 x 
LysM Crepos mice, which have reduced intracellular MPO activity. Based on these 
observations, mainly extracellular MPO is supposed to be involved in liver damage 
during LCMV-induced hepatitis. Therefore, we inhibited extracellular MPO in wt mice 
over the whole course of acute LCMV-infection. 
The compound 4-Aminobenzoic acid hydrazide (4-ABAH) irreversibly inhibits MPO 
activity [143]. Upon in vivo application, largely extracellular MPO is inhibited due to 
poor cell membrane permeability of 4-ABAH [144, 145]. To assess the role of 
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extracellular MPO in LCMV-induced acute hepatitis, wt mice were treated every 
second day from day 1 p.i. with 4-ABAH over the course of infection. 
On day 7 p.i., in mice treated with 4-ABAH, serum AST activity was at about 1100 
U/L and at about 850 U/L in vehicle treated control mice (Fig. 26). Importantly, AST 
levels did not increase in 4-ABAH-treated mice by day 8 p.i.. Whereas in control mice 
significantly higher levels of about 2200 U/L were reached, 4-ABAH treated mice 
remained at levels of about 1100 U/L. 
Previously, we observed that MPO-deficiency did not impair virus elimination. To test, 
whether 4-ABAH impacts virus elimination from the liver and the spleen, viral loads 
were quantified on days 7 and 8 p.i.. Indeed, the inhibitor had no influence on virus 
elimination, since viral loads in the liver and the spleen were similar in mice treated 
with 4-ABAH and in vehicle-treated mice (Fig. 27).  
To further examine, whether 4-ABAH has an influence on immune cell recruitment to 
the liver, infiltration of CD8+ T cells, CD4+ T cells and CD11b+/Ly6Ghi neutrophils 
among leukocytes was assessed by flow cytometry. On day 7 p.i., the frequencies of 
infiltrating CD8+ T cells in the liver reached about 35 % among leukocytes in both 
groups (Fig. 28A). On day 8 p.i., CD8+ T cell frequencies similarly rose to about 40 % 
in both groups (Fig. 28A). To elucidate, if the generation of virus-specific CD8+ T 
cells was manipulated by 4-ABAH, TCRLCMV
+ T cells were analyzed by flow cytometry 
on day 8 p.i.. In both, 4-ABAH-treated and control mice, about 30 % among CD8+ T 
cells expressed TCRLCMV. On days 7 and 8 p.i., the frequencies of infiltrating CD4
+ T 
cells in the liver were at about 5 % among leukocytes in both groups (Fig. 28B). 
On day 7 p.i., about 8 % were CD11b+/Ly6Ghi neutrophils in mice treated with 4-
ABAH and in control mice (Fig. 28C). On day 8 p.i., in mice treated with 4-ABAH and 
in control mice, frequencies of neutrophils were similar at about 10 %. 
Altogether, these data show that upon in vivo inhibition of extracellular MPO activity 
with 4-ABAH, LCMV-induced liver damage is significantly reduced on day 8 p.i.. Virus 
elimination and immune cell recruitment, as well as the generation of virus-specific 
CD8+ T cells are not affected. Importantly, in vivo inhibition of extracellular MPO 
induces a similar phenotype observed in mice with constitutive knockout of MPO. 
This strengthens the conclusion that predominantly extracellular MPO contributes to 
immunopathology during LCMV-induced hepatitis. 
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Fig. 26 Serum AST activity in wt mice upon inhibition of extracellular MPO with 4-
ABAH 
Groups of Bl/6J wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Extracellular MPO was inhibited from day 1 p.i. by i.p. injection of 625 µg 4-ABAH every 
second day over the course of infection. Control mice were vehicle-treated with 15 % DMSO 
in PBS. Serum samples were prepared on the indicated days p.i. and activity of the 
transaminase AST was measured. Shown are cumulative data as means ±SEM from 1 (day 
7) and 3 (day 8) experiments with n = 2 (day 7) and n = 15 mice per group. Statistical 
significance was assessed by Student´s t-test and is indicated by * for p≤0.05. 
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Fig. 27 Viral loads in the liver and the spleen upon inhibition of extracellular MPO 
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-Continued legend- 
Fig. 27 Viral loads in the liver and the spleen upon inhibition of extracellular MPO 
Groups of Bl/6J wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Extracellular MPO was inhibited by i.p. injection of 625 µg 4-ABAH every second day over 
the course of infection, from day 1 p.i. on. Control mice were vehicle-treated with 15 % 
DMSO in PBS. Viral loads in (A) liver and (B) spleen as [log10 (PFU/g)] were determined on 
the indicated days p.i.. Shown are cumulative data as means ±SEM 1 (day 7) and 2 (day 8) 
experiments with n = 3 (day 7), n = 8 (day 8) mice per group. 
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Fig. 28 Immune cell infiltration in the liver upon inhibition of extracellular MPO 
Groups of Bl/6J wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Extracellular MPO was inhibited by i.p. injection of 625 µg 4-ABAH every second day over 
the course of infection. Control mice were vehicle-treated with 15 % DMSO in PBS. In the 
perfused liver, percentages of (A) CD8+ and TCRLCMV
+/CD8+ (B) CD4+ and (C) 
CD11b+/Ly6Ghi cells among leukocytes were determined by flow cytometry. TCRLCMV
+/CD8+ 
cells were detected with MHC dextramers loaded with LCMV-specific epitopes (MHC I alleles 
and epitopes: H-2Db-restricted immunodominant epitopes GP33-41, GP276-286, and NP396-404). 
From these data, the frequencies of LCMV-specific CD8+ T cells were calculated as follows: 
% TCRLCMV
+ CD8+ cells / % CD8+ liver lymphocytes x 100 %. Column diagrams show 
cumulative data of the frequencies of CD8+, TCRLCMV
+/CD8+, CD4+ and CD11b+/Ly6Ghi liver 
cells as means ±SEM from 1 experiment (day 7) and 2 experiments (day 8) with n = 3 (day 7) 
and n = 6 (day 8) per group. 
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3.6  Mechanisms of MPO-induced hepatocyte death 
 
Reactive oxidants generated by MPO can be cytotoxic for a variety of cell 
types e.g. endothelial cells, epithelial cells and fibroblasts (reviewed in [23]) [146-
148]. Beyond that, MPO was also reported to be associated with the regulation of 
cellular processes, such as TGFβ signaling and growth arrest [30, 149]. We therefore 
wanted to elucidate, whether MPO has an influence on TGFβ-mediated processes or 
the cell cycle of hepatocytes during acute LCMV-induced hepatitis. 
 
 
3.6.1  The role of MPO on the transcriptional regulation of NADPH oxidase 4 
 
 Upregulation of NOX4 can potentiate oxidative stress in hepatocytes [150]. 
One factor, which is involved in the transcriptional regulation of NOX4 is the 
transforming growth factor beta (TGFβ). TGFβ was reported to upregulate NOX4 
expression, which correlated with pro-apoptotic activity in hepatocytes [151]. 
We wanted to investigate, whether MPO has an impact on the regulation of NOX4 
during LCMV-induced hepatitis and if this may cause increased liver damage in wt 
mice. For that purpose, TGFβ and NOX4 expression in the liver of MPO-/- and wt 
mice were analyzed by qRT-PCR. On day 8 p.i., TGFβ expression in the liver did not 
differ in MPO-/- and wt mice (Fig. 29A). Additionally, NOX4 expression was similar in 
MPO-/- and wt mice on day 8 p.i. (Fig. 29B). 
These data show that at the peak of LCMV-induced acute hepatitis on day 8 p.i., 
MPO has no influence on TGFβ and NOX4 expression. This indicates that 
exacerbated liver damage in wt mice is not due to a potentiation of oxidative stress 
by an increase in NOX4-generated ROS. 
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 A            B 
 
 
 
 
 
 
 
 
Fig. 29 Expression of TGFβ and NOX4 in the liver on day 8 p.i. 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
RNA was extracted from liver samples and qRT-PCR for expression of (A) TGFβ and (B) 
NOX4 was performed using DNA-binding dye SYBR green. Expression is shown relative to 
expression of β-actin as ±SEM of cumulative data from 3 experiments with n = 8 MPO-/- mice 
and n = 8 wt mice for TGFβ and from 3 experiments with n = 10 MPO and from 3 
experiments with n = 10 MPO-/- mice and n = 11 wt mice. 
 
 
3.6.2 Cell cycle progression of hepatocytes over the course of acute LCMV 
infection 
 
To test, whether MPO influences the cell cycle of hepatocytes during LCMV-
induced hepatitis the expression of the cell cycle-associated proteins p53 and p21 in 
the liver was analyzed by qRT-PCR on day 8 p.i. (Fig. 30). However both, MPO-/- and 
wt mice expressed p53 and p21 to a similar extent. 
In 2015 a study by Beier et al., infection of wt mice with LCMV, strain WE, resulted in 
impaired cell cycle progression of hepatocytes [152]. We wanted to investigate, if 
MPO has an impact on cell cycle progression of hepatocytes during infection of mice 
with LCMV. For this purpose, mitosis of primary hepatocytes from naïve and infected 
MPO-/- and wt mice was analyzed by flow cytometry via Propidium iodide (PI) 
staining. DNA staining with PI of fixed cells allows the quantification of DNA contents 
during mitosis, by which the interphases can be discriminated [153]. 
In naïve MPO-/- and wt mice, about 40 % of hepatocytes were in the G0/G1 phase of 
mitosis. In both, about 5 % of hepatocytes were in the S phase and 55 % had 
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entered the G2 phase (Fig. 31A). The frequencies of hepatocytes in G0/G1, S or G2 
phase were similar in naïve MPO-/- and wt mice. Beier et al. observed an 
accumulation of hepatocytes arrested in the G0/G1 phase on day 4 p.i.. However, our 
analysis revealed that about 55 % of hepatocytes accumulated in the G0/G1 phase in 
both MPO-/- and wt mice on day 4 p.i. (Fig. 31B). About 5 % had entered the S 
phase, while about 40 % were in the G2 phase, indicating cell cycle progression. On 
day 8 p.i., about 25 % of hepatocytes were in the G0/G1 phase (Fig. 31C). 10 % had 
started DNA synthesis in the S phase and about 65 % had reached the G2 phase. 
Taken together, there was no difference between MPO-/- and wt mice at each time 
point of measurement.These data show that the regulation of the cell cycle 
associated genes p53 and p21 was independent of MPO. Additionally, infection of 
mice with LCMV, strain WE, indeed slightly altered cell cycle progression over the 
course of infection. However, MPO had no influence on this mechanism, since cell 
cycle progression was similar in MPO-/- and wt mice. 
 
 
A             B 
 
 
 
 
 
 
 
 
Fig. 30 Expression of cell cycle-associated genes p53 and p21 in the liver on day 8 p.i. 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
RNA was extracted from liver samples and qRT-PCR for expression of (A) p53 and (B) p21 
was performed using DNA-binding dye SYBR green. Expression is shown relative to 
expression of β-actin as ±SEM of cumulative data from 3 experiments with n = 8 MPO-/- mice 
and n = 8 wt mice. 
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A          B     C 
 
 
 
 
 
 
 
 
 
 
Fig. 31  Cell cycle progression of hepatocytes over the course of LCMV-induced acute 
hepatitis 
Groups of MPO-/- and wt mice were infected by i.p. injection of 106 IU of LCMV, strain WE. 
Cell cycle analysis was performed in (A) naïve mice and on (B) day 4 or (C) day 8 p.i.. Single 
cell suspension of the liver was fixed and after RNase treatment, DNA was stained with 
Propidium iodide. Hepatocytes were gated by appearance in FSC and SSC. G0/G1, S and 
G2 phase were discriminated by DNA content. Shown are positively stained cells in % as 
±SEM of cumulative data from 1 experiment (day 0), 1 experiment (day 4) and 2 experiments 
(day 8) with n = 2 (days 0 and 4) and n = 6 MPO-/- and wt mice. 
 
 
Altogether these data indicate that MPO had no influence on the expression TGFβ or 
NOX4, which can also be involved in liver damage. Furthermore, MPO did not impact 
the expression of cell cycle associated genes or cell cycle progression. 
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4 Discussion 
 
Neutrophils are recruited shortly after microbial invasion of the host as first 
responders to infections (reviewed in [41]). At the site of infection, they eliminate 
pathogens by several mechanisms, namely phagocytosis, degranulation, and the 
release of neutrophil extracellular traps (reviewed in [154]). Neutrophils express a 
variety of antimicrobial molecules, which are critically involved in the abovementioned 
processes. Besides the inactivation invading pathogens, these molecules may also 
induce host tissue damage (reviewed in [43]). 
The most abundant of antimicrobial molecules of neutrophils is the heme enzyme 
myeloperoxidase (MPO), which generates highly reactive oxidants, e.g. hypochlorous 
acid (reviewed in [7]). The role of MPO in the defense of bacterial infections has been 
well characterized for decades (reviewed in [11, 12]). For viral infections, there are 
only few studies about the role of MPO (reviewed in [49, 50]).  
ROS-induced oxidative stress may have a critical role in liver pathology in patients 
infected with hepatitis B virus (HBV) [155, 156]. In hepatitis C virus (HCV) infection, 
pathophysiology was also associated with increased levels of oxidative damage 
[157]. Another study about chronic HCV infection revealed that MPO levels in the 
plasma and liver tissue of patients correlated with liver aminotransferases AST and 
ALT, both important indicators of liver injury [53]. Worldwide, about 400 million people 
suffer from potentially life-threatening infections with hepatitis B and C, causing both 
acute and chronic disease (reviewed in [158, 159]). Therefore, it is of high clinical 
relevance to understand the basic biomedical mechanisms in order to therapeutically 
treat these diseases. However, the host range of the abovementioned hepatitis 
viruses is limited to humans and chimpanzees, small animal models are barely 
available [160]. 
 
The Lymphocytic Choriomeningitis Virus (LCMV) is a pathogen intensively used in 
murine models to reveal and characterize basic immune mechanisms. We used the 
murine LCMV model to explore the role of MPO in an anti-viral immune response. 
Acute LCMV infection induces a vigorous virus-specific immune response, which 
leads to rapid elimination of the virus. Importantly, depending on the route of virus 
inoculation, LCMV induces various immunopathological syndromes, including acute 
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hepatitis, choriomeningitis, or a delayed-type hypersensitivity (DTH) reaction 
(reviewed in [120]) [99]. 
Infection of mice with LCMV via i.p. inoculation causes a fulminant, but transient 
hepatitis [99]. Our experiments revealed that mice with MPO deficiency (MPO-/-) had 
substantially decreased immunopathology during acute LCMV-induced hepatitis 
compared to wt animals. Additionally, MPO-/- mice had significantly lower 
transaminase activity in the serum. This was accompanied with a strong reduction in 
cleaved caspase 3 levels in the liver, which indicates reduced activation of apoptosis 
in these mice (reviewed in [161]) [162]. Thus, LCMV-induced liver pathology is 
partially dependent on MPO. 
Regarding LCMV-induced meningitis, a study by McGavern et al. (2009) revealed 
that acute lethality after i.c. injection of LCMV depends on infiltrating neutrophils and 
monocytes causing vascular leakage in the brain [97]. Simultaneous depletion of 
both cell types extended survival by three days, while depletion of one cell type alone 
was not beneficial. When we intracerebrally infected MPO-/- mice with LCMV, the 
course of meningitis and acute lethality were similar to wt mice. Hence, mortality due 
to LCMV-induced meningitis appears to be mediated by other factors, but MPO. 
The LCMV-induced DTH reaction is a T cell-dependent process. It is characterized 
by a transient, biphasic swelling reaction after s.c. inoculation into the hind footpad, 
sequentially mediated by CD8+ and CD4+ T cells [163, 164]. The potential impact of 
MPO on footpad swelling was compared in MPO-/- and wt mice over the course of 
infection. Our data demonstrate that the course of footpad swelling during LCMV-
induced DTH reaction was independent of MPO  
Altogether, the analysis of these three LCMV-induced immunopathological 
syndromes revealed that in acute infection of mice with LCMV, the involvement of 
MPO in immunopathology was solely restricted to the liver. 
 
MPO-deficiency had an ameliorating effect on LCMV-induced immune-mediated 
hepatitis. Since LCMV is a non-cytopathic virus, tissue damage is largely mediated 
by the host´s immune response (reviewed in [81]) [82, 83]. To elucidate the impact of 
MPO on the virus-specific immune response, the course of acute hepatitis was 
characterized in MPO-/- mice over 10 to 14 days. 
LCMV-induced immunopathology in the liver is induced consecutively by NK cells, 
CD8+ T cells and CD4+ T cells (reviewed in [84]) [165]. Clearance of the virus is 
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accomplished by CD8+ T cells, which are necessary and sufficient for virus 
elimination within 10 to 14 days [86, 166]. Upon activation, virus-specific CD8+ T cells 
expand up to 16.000-fold in the spleen and migrate to infected tissues [84]. In the 
periphery, the virus is eliminated by T cell-mediated, MHC class I-restricted induction 
of apoptosis of infected cells.  
In intraperitoneally infected MPO-/- and wt mice, viral loads in the liver and the spleen 
were similar in both genotypes over the whole course of infection. This suggests that 
MPO is not involved in virus control during acute LCMV-induced hepatitis.  
In this context, a recent publication of Lang and colleagues requires consideration. 
They observed a highly significant reduction in LCMV-induced liver immunopathology 
in mice with p47phox-deficiency [167]. The p47phox subunit, i.e. the organizing subunit 
of the NADPH oxidase 2 (NOX2) complex, is indispensable for the assembly of the 
functional NOX2 complex (reviewed in [8]). Lang et al. observed lower ROS 
production in granulocytes of p47phox-deficient mice accompanied by a more robust 
LCMV-specific immune response of CD8+ T cells. 
NOX2 and MPO are functionally connected, since MPO uses NOX2-derived ROS to 
produce highly reactive oxidants, i.e. hypochlorous acids. In our model, the 
expansion of CD8+ and CD4+ T cells was not affected by MPO and the generation of 
LCMV-specific CD8+ T cells was similar in MPO-/- and wt mice. In addition, the 
recruitment of CD8+ and CD4+ T cells to the liver was independent of MPO. Beyond 
that, MPO had no impact on the LCMV-specific cytotoxic activity of splenic or hepatic 
CD8+ T cells. 
Taken together, unlike in mice with p47phox-deficiency, MPO-deficiency has no effect 
on the generation of an LCMV-specific T cell response. NOX2 is the most widely 
distributed among the family of NOX isoforms (reviewed in [8]). Its expression is 
reported for various cell types and tissues [168]. In contrast, MPO expression is 
solely restricted to a few myeloid cells [169]. We suspect that deficiency in NOX2 
may cause a more drastic reduction in ROS production, which might have distinct 
effects on the LCMV-specific T cell response, than deficiency in MPO. 
 
In human blood up to 70 % among leukocytes are neutrophils [3]. The most 
abundantly expressed protein in neutrophils is MPO, which ranges from 2 - 5 % of 
total cellular protein. In mice, only 10-15 % of leukocytes are neutrophils and MPO 
levels per cell are about 10-times lower as compared to humans [170, 171]. Apart 
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from that, there is little information available, which cells beyond neutrophils actually 
express MPO in mice. One of the few studies about cell-specific MPO expression in 
rodents revealed that in the liver of rats, MPO expression was exclusively detected in 
neutrophils [5]. During LCMV-induced acute hepatitis, we identified neutrophils as the 
major cell type expressing MPO. Considerably lower amounts of MPO were detected 
in monocytes and macrophages. In humans, monocytes were reported to lose MPO 
activity upon tissue infiltration and differentiation into macrophages [172]. 
Furthermore, several independent groups demonstrated that the detection of MPO in 
these two cell types might be due to phagocytosis of apoptotic neutrophils or 
extracellular MPO (reviewed in [173]) [131, 174]. Thus, for the following 
investigations, we considered MPO in neutrophils to be predominantly involved in 
LCMV-induced immunopathology. 
 
In bacterial infections, neutrophils are characterized as short-lived first line 
responders, which are recruited to the site of infection within 15 to 30 minutes 
(reviewed in [40, 41, 175, 176]). In contrast, during LCMV-induced hepatitis, the 
frequencies of liver-infiltrating neutrophils did not increase within the first few days 
after infection. Instead, the course of neutrophil recruitment to the liver paralleled the 
kinetics of the adaptive immune response of CD8+ T cells. Recruitment of both, CD8+ 
T cells and neutrophils peaked on day 8 p.i.. This correlated with maximum liver 
damage. Hence, neutrophils might contribute to LCMV-induced immunopathology 
several days after infection rather than in the first hours or days. Consequently, we 
hypothesized that in vivo depletion of neutrophils over the course of infection might 
ameliorate the symptoms of hepatitis.  
On the first two days after infection viral loads in the liver and the spleen tended to 
barely differ in mice depleted of neutrophils and control mice. These data were 
collected from small mouse groups. However, this suggests that neutrophils seem to 
be dispensable for viral control early after LCMV infection. 
On days 7 and 8 p.i., virus titers in the liver and the spleen, as well as serum 
transaminase levels were strongly increased after neutrophil depletion. At these time 
points, neutrophils appeared to be involved in limiting immunopathology especially at 
the peak of the CD8+ T cell response on day 8 p.i.. Thus, the treatment of mice with a 
neutrophil-depleting antibody severely aggravated the course of hepatitis.  
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A recent publication revealed that neutrophils suppressed the CD8+ T cell response 
at the immune contraction phase on day 14 p.i. after infection of mice with LCMV, 
strain clone 13 [133]. This observation suggests that after infection of mice with 
LCMV, strain WE, neutrophils might also be involved in controlling immunopathology. 
Nevertheless, the dynamics of the immune response may largely differ according to 
the LCMV strain. For instance, strains WE and Armstrong cause acute infections and 
induce a strong virus-specific immune response, which peaks between days 7 and 8 
leading to rapid virus elimination [177]. In contrast, the acute immune response 
against LCMV, clone 13 peaks on day 6 p.i. [178]. However, instead of being 
eliminated, clone 13 establishes a persisting infection as a consequence of CD8+ T 
cell exhaustion (reviewed in [84]) [179]. 
Based on the diverse courses of infection with various LCMV strains, the potential 
role of neutrophils in immunoregulation during the acute immune response against 
LCMV WE remains to be elucidated in detail. This requires extensive characterization 
of the heterogeneity of neutrophil phenotypes over the course of infection. In humans 
the CD11bhi/CD62Ldim subset was described to inhibit T cell proliferation ex vivo 
[180]. Furthermore, neutrophils can exert immunosuppression by ROS production 
(reviewed in [181]). By means of the abovementioned information, possible 
phenotypic alterations of neutrophils may be identified over the course of infection 
with LCMV WE. 
Together, our findings support the view that neutrophils display an array of functions 
influencing both innate and adaptive immune responses [182].  
 
The above described data revealed that neutrophils appear to be involved in 
immunoregulation during LCMV-induced hepatitis, but in a rather surprising way. The 
depletion of neutrophils over the course of infection severely aggravated 
immunopathology. Thus, neutrophils seem to be involved in dampening the disease. 
Contrarily, expression of MPO, which is predominantly restricted to neutrophils, 
promotes liver damage in wt mice. This suggests an involvement of MPO in 
immunopathology independent of the potential immunoregulatory functions of 
neutrophils. 
In wt mice, MPO levels in the liver and the plasma were strongly increased by day 8 
p.i.. We hypothesized that high tissue and plasma concentrations of MPO might 
potentiate LCMV-induced immunopathology. MPO was reported to contribute to 
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tissue damage in several ways (reviewed in [7]). MPO, which is released to the 
extracellular environment by degranulation of granulocytes can damage host cells 
and tissues (reviewed in [140]). Intracellularly, hypochlorous acid generated by MPO 
contributes to the inactivation of phagocytosed pathogens (reviewed in [12]). 
Additionally, intracellular MPO activity may mechanistically influence the cellular 
response of neutrophils themselves. Several studies revealed that hypochlorous acid 
could influence cellular processes e.g. by influencing the regulation of transcription 
factors, such as NFκB or p53 in various cell types (reviewed in [23]) [148, 183]. 
We aimed at analyzing to which extent intracellular MPO is involved in tissue damage 
during LCMV-induced hepatitis. Since it is not possible to exclusively inhibit 
intracellular MPO, we resorted to mice with NOX2-deficiency in myeloid cells (NOX2 
x LysM Crepos) as an independent approach. In NOX2-deficient phagocytes 
intracellular ROS production is strongly reduced [137]. Intracellular MPO 
predominantly uses NOX2-derived ROS to generate hypochlorous acid (reviewed in 
[184]). Thus, due to low production of intracellular hydrogen peroxide, NOX2 x LysM 
Crepos mice should have strongly reduced intracellular MPO activity. In these mice, 
the course of hepatitis was not altered, suggesting that immunopathology is 
independent of intracellularly produced NOX2-derived ROS and hypochlorous acid in 
myeloid cells.  
Extracellular MPO is rather linked to tissue damage than to host defense (reviewed in 
[7, 41, 185]). To elucidate its contribution to immunopathology, extracellular MPO 
was inhibited in vivo. The enzymatic activity of MPO can be irreversibly inactivated by 
the compound 4-ABAH, which is applicable in vivo [143]. MPO oxidizes 4-ABAH to a 
radical, which reduces MPO itself to an inactive intermediate. Upon in vitro or in vivo 
application, predominantly extracellular MPO is inhibited due to poor membrane 
permeability of 4-ABAH [144, 145]. 
On day 8 p.i., when the LCMV-specific immune response peaks, serum transaminase 
levels were significantly reduced after treatment of wt mice with 4-ABAH. This was 
not due to interference of 4-ABAH with the T cell response, since T cell recruitment to 
the liver, virus-specificity of CTLs and virus elimination were not affected in these 
mice. 
These findings are in line with the in vivo data of MPO-/- mice. Here, the T cell 
response and virus elimination were not altered, while immunopathology was 
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ameliorated in the absence of MPO. This suggests that mainly extracellular MPO 
contributes to immunopathology during LCMV-induced acute hepatitis. 
When MPO is released to the extracellular environment by NETosis, it can also 
contribute to host tissue damage (reviewed in [186]). In human neutrophils, NETosis 
was reported to be dependent on the presence of MPO according to the stimulus 
(reviewed in [139]) [187, 188]. Human MPO-/- neutrophils stimulated with PMA were 
less efficient in producing NETs, while treatment with Pseudomonas aeruginosa, 
Staphylococcus aureus, or Escherichia coli had no effect on NETosis.  
Therefore, the relevance of MPO for the induction of NETosis in response to LCMV 
was investigated. The treatment of bone marrow-derived neutrophils from naïve 
MPO-/- mice with LCMV led to release of DNA in vitro. However, the frequency of 
NETosis was similar in MPO-/- and wt mice. This implies that NETosis in response to 
LCMV appears to be independent of MPO. In accordance with our findings, a study 
by Akong-Moore et al. revealed that MPO inhibition or knock-out did not impair 
NETosis in murine neutrophils stimulated with PMA [189].  
The impact of extracellular MPO on the survival of hepatocytes was further 
elucidated. We and others observed that extracellularly added MPO caused 
hepatocyte death in the presence of hydrogen peroxide in vitro [30]. Moreover, the 
frequency of hepatocyte death was dependent on the MPO concentration. In parallel, 
our data indicate that hepatocyte death in vivo might also be related to systemic and 
tissue levels of MPO. For the most part, LCMV-induced immunopathology in the liver 
is mediated by virus-specific CTLs, which are sufficient to clear the infection [99]. 
Nevertheless in infected wt mice, we detected co-localization of MPO with apoptotic 
liver cells to a considerable degree.  
Together, these data indicate that immunopathology was independent of intracellular 
MPO activity. Additionally, LCMV induced NETosis in neutrophils did not require 
MPO. Nevertheless, this mechanism might contribute to immunopathology in wt 
mice, since MPO is released to the extracellular environment as component of NETs 
(reviewed in [42]). Based on these observations, we assume that contact with 
extracellular MPO may contribute to hepatocyte death during LCMV-induced 
hepatitis. 
 
The abovementioned data suggest that MPO may directly exert cytotoxicity most 
likely by causing oxidative damage and subsequent cell death via production of 
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highly reactive oxidants. This may involve induction of the apoptosis machinery. We 
wanted to reveal potential mechanisms leading to hepatocyte death depending on 
MPO activity, especially at the peak of immunopathology on day 8 p.i.. 
In this context, TGFβ was reported to be involved in several mechanisms promoting 
liver immunopathology induced by various stimuli (reviewed in [190]). The 
abovementioned publication by Pulli et al. revealed that in a model of non-alcoholic 
steatohepatitis (NASH), MPO-derived ROS induced TGFβ. This led to activation of 
hepatic stellate cells (HSCs), which contributed to fibrosis by increased production of 
collagen. In our model, MPO had no influence on TGFβ expression in the liver. 
Additionally in both MPO-/- and wt mice, liver fibrosis was absent on day 8 p.i.. Thus, 
MPO-mediated immunopathology in acute LCMV-induced hepatitis did not involve 
TGFβ [190]. 
Mechanistically, liver injury can also be due to potentiated oxidative stress by 
upregulation of NOX4 expression in hepatocytes [151, 191]. NOX4 is a constitutively 
active enzyme and the modulation of its activity is only achieved by transcriptional 
regulation (reviewed in [8]). This was reported to be regulated by TGFβ [151, 191]. 
Beyond TGFβ, NOX4 expression could potentially be regulated by other factors, such 
as MPO. We hypothesized that an MPO-dependent enhancement of NOX4 
expression could aggravate liver damage in wt mice. However on day 8 p.i., NOX4 
expression in the liver was similar in both MPO-/- and wt mice. This suggests that the 
milder course of immunopathology in MPO-/- mice was not due to MPO-mediated 
NOX4 regulation. 
ROS can activate the transcription factor p53, which is involved in the induction of 
apoptosis by caspase activation in response to cellular stress (reviewed in [192, 
193]), [194]. Moreover, p53 induces the cyclin-dependent kinase inhibitor p21, which 
is involved in the promotion of cell cycle arrest. Beier et al. reported in 2015 that 
acute infection of mice with LCMV WE caused cell cycle arrest of hepatocytes in the 
G1-phase of mitosis, which finally led to apoptosis [152]. 
In MPO-/- mice acutely infected with LCMV, the levels of cleaved caspase 3 were 
significantly lower, indicating reduced apoptosis in the liver of MPO-/- mice. We 
wanted to elucidate, whether hepatocyte death was due to differential regulation of 
p53 and p21, or cell cycle arrest in MPO-/- and wt mice. The expression of p53 and 
p21 was similar in both, MPO-/- and wt mice. Thus, during LCMV-induced hepatitis, 
both genes appear to be regulated independent of MPO-derived oxidants. 
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Acute infection of mice with LCMV influenced the distribution of hepatocytes in the 
cell cycle phases. Nevertheless, we could not detect the accumulation of hepatocytes 
in the G1, S or G2 phase, neither in MPO-/- mice nor in wt mice. Beyond that, the 
distribution of hepatocytes in the G0/1, S or G2 phase was similar in MPO-/- and wt 
mice over the course of infection. In contrast to Beier et al., we applied a more 
quantitative technique for the determination of cell cycle progression. In our 
experimental setup, DNA contents of single cell suspensions of the whole liver were 
stained with PI and quantitatively analyzed by flow cytometry. The authors used 
proliferating-cell-nuclear antigen (PCNA) staining of liver sections by 
immunohistochemistry. By this technique, the distinct mitosis states can be 
qualitatively determined according to intracellular PCNA distribution [195]. In 
comparison, flow cytometry allows a more quantitative analysis of the cell cycle. 
Taken together in LCMV-induced acute hepatitis, it appears that MPO-mediated 
immunopathology does not involve the induction of p53- and p21-mediated apoptosis 
or cell cycle arrest in the G1, S or G2 phase of mitosis. 
 
Altogether, we identified MPO as a so far unknown player in immunopathology during 
LCMV-induced hepatitis. The effects of MPO during acute infection of mice with 
LCMV were restricted to the liver. MPO-deficiency significantly ameliorated the 
course of acute hepatitis without affecting the virus-specific T cell response, or the 
elimination of the virus. In our model, neutrophils were the predominant cell type 
expressing MPO. Instead of being recruited early after infection, neutrophil infiltration 
to the liver and MPO levels paralleled the course of the adaptive immune response of 
CD8+ T cells. Surprisingly, neutrophil depletion severely aggravated the course of 
hepatitis. The in vivo application of the MPO-inhibitor 4-ABAH revealed that inhibition 
of extracellular MPO significantly dampens LCMV-induced immunopathology, as 
does MPO-deficiency. In line with this, extracellularly added MPO induced 
hepatocyte death in vitro. Furthermore, immunofluorescence microscopy revealed 
that MPO partially co-localized with apoptotic hepatocytes.  
These data suggest that MPO might be a potential target to therapeutically attenuate 
the clinical course of viral hepatitis. In this context one should consider that in 
humans, MPO levels are about ten-times higher than in mice, which might even 
enhance the health-promoting effect of MPO-inhibition in patients (reviewed in [7]). 
MPO-deficient individuals do not suffer from infections and are typically 
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asymptomatic (reviewed in [196-199]). Thus, adverse effects of blocking MPO activity 
are not obvious. 
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6 Summary 
 
 Myeloperoxidase (MPO)-derived ROS constitute an important part of the 
neutrophil-mediated antimicrobial activity. In bacterial and parasitic infections, MPO 
has been extensively studied as a major microbicidal molecule against such 
pathogens. The role of MPO in viral infections is less clear. Depending on the virus, 
MPO has been shown to contribute to viral clearance. However, excessive release of 
MPO over the course of viral infections was also associated with host tissue damage. 
The Lymphocytic Choriomeningitis Virus (LCMV), strain WE, causes acute infections 
in mice. LCMV is a non-cytopathic virus, thus immunopathology is largely mediated 
by virus-specific CD8+ T cells, which lyse infected host cells. 
The question, to what extent MPO contributes to LCMV-induced immunopathology 
has not been addressed, yet. We report here that MPO-deficiency (MPO-/-) 
specifically ameliorated the course of immunopathology during acute LCMV-induced 
hepatitis in mice. Depending on the route of virus inoculation, LCMV induces further 
immunopathological syndromes, i.e. lethal choriomeningitis or a delayed-type 
hypersensitivity (DTH) reaction. Interestingly, these two syndromes were not altered 
in MPO-/- mice, the ameliorating effect was only restricted to the liver. Remarkably, 
the strong virus-specific T cell response and virus control were independent of MPO. 
Instead, the kinetics of neutrophil recruitment to the liver and MPO plasma and tissue 
levels paralleled the course of hepatitis. Surprisingly, neutrophil depletion over the 
course of infection severely aggravated immunopathology, suggesting 
immunoregulatory functions beyond the effect of MPO. The in vivo inhibition of 
extracellular MPO during LCMV-induced hepatitis significantly attenuated the 
disease, while intracellular MPO activity was not involved in this process. In 
accordance with this, extracellularly added MPO caused hepatocyte death in vitro 
and apoptotic hepatocytes partially co-localized with MPO in vivo. 
 
This study documents a physiological role of extracellular MPO in contributing to 
immunopathology in LCMV-induced acute hepatitis, without affecting the virus-
specific T cell response or viral clearance. 
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6 Zusammenfassung 
 
Von der Myeloperoxidase (MPO) generierte reaktive Sauerstoffspezies bilden 
einen wichtigen Teil der antimikrobiellen Aktivität von Neutrophilen. Aus einer 
Vielzahl von Studien ging hervor, dass die MPO in bakteriellen und parasitären 
Infektionen von großer Bedeutung für die Abwehr diverser Erreger ist. Die Rolle der 
MPO in viralen Infektionen hingegen ist weniger gut charakterisiert. Es wurde 
gezeigt, dass die MPO bei einigen Viren zu deren Eliminierung beitragen kann. 
Allerdings wurde die Aktivität der MPO auch mit der Schädigung von verschiedenen 
Geweben assoziiert. 
Die akute Infektion der Maus mit dem Lymphozytäre Choriomeningitis Virus (LCMV), 
Stamm WE, ist ein anerkanntes Modell. Immunpathologie wird dabei hauptsächlich 
von Virus-spezifischen CD8+ T Zellen vermittelt, da LCMV ein nicht-zytopathisches 
Virus ist. 
Die Frage, ob die MPO zu der durch LCMV vermittelten Immunpathologie beiträgt, 
wurde bisher nicht untersucht. Diese Arbeit zeigt, dass MPO-Defizienz (MPO-/-) die 
Immunpathologie über den Infektionsverlauf einer durch LCMV induzierten, akuten 
Hepatitis in Mäusen deutlich verringert. Abhängig von der Infektionsroute induziert 
LCMV weitere immunpathologische Syndrome, wie eine letale Choriomeningitis oder 
eine Hypersensitivitätsreaktion vom verzögerten Typ. Diese zwei Syndrome waren in 
MPO-/- Mäusen unverändert. Interessanterweise waren die starke Virus-spezifische T 
Zellantwort und die Viruskontrolle unabhängig von der MPO. Stattdessen verliefen 
die Kinetik der Rekrutierung von Neutrophilen in die Leber und der MPO Level im 
Plasma und Gewebe parallel zum Verlauf der Hepatitis. Die Depletion von 
Neutrophilen über den Infektionsverlauf steigerte die Immunpathologie 
überraschenderweise stark. Dies lässt eine immunregulatorische Funktion von 
Neutrophilen, unabhängig von der MPO vermuten. Die in vivo Inhibition der 
extrazellulären MPO während der durch LCMV induzierten Hepatitis hingegen, 
verbesserte die Symptome signifikant. Die intrazelluläre MPO war nicht in diesen 
Prozess involviert. In Übereinstimmung damit, induzierte die in vitro Behandlung von 
Hepatozyten mit der MPO, deren Zelluntergang. In vivo waren apoptotische 
Hepatozyten teilweise in Ko-lokalisation mit der MPO zu finden. 
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Diese Arbeit zeigt, dass die extrazelluläre MPO zur Immunpathologie während der 
durch LCMV induzierten Hepatitis beiträgt, ohne dabei die T Zellantwort oder 
Viruskontrolle zu beeinträchtigen. 
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